| 1 |
Vyas K, Patel MM. Insights on drug and gene delivery systems in liver fibrosis. Asian J Pharm Sci 2023;18:100779. [PMID: 36845840 DOI: 10.1016/j.ajps.2023.100779] [Reference Citation Analysis]
|
| 2 |
Zhang B, Bottenus N, Jin FQ, Nightingale KR. Quantifying the Impact of Imaging Through Body Walls on Shear Wave Elasticity Measurements. Ultrasound Med Biol 2023;49:734-49. [PMID: 36564217 DOI: 10.1016/j.ultrasmedbio.2022.10.005] [Reference Citation Analysis]
|
| 3 |
Hui-Ling C, Kang-Ming H, Yu Z, Yin-Han D, Huang D, Shu-Ping X, Hong-Bin C. The potential value of serum GP73 in the ancillary diagnosis and grading of liver cirrhosis. Scand J Clin Lab Invest 2023;:1-8. [PMID: 36786815 DOI: 10.1080/00365513.2023.2175238] [Reference Citation Analysis]
|
| 4 |
Dasgupta T, Manickam V. Fibrosis in Liver and Pancreas: a Review on Pathogenic Significance, Diagnostic Options, and Current Management Strategies. Inflammation 2023. [PMID: 36595108 DOI: 10.1007/s10753-022-01776-0] [Reference Citation Analysis]
|
| 5 |
ElShahawy A, El-Raziky MS, Sharaf SA, Elsharkawy A, Enayet A, Taher H. Accuracy of noninvasive methods for the diagnosis of liver fibrosis in children with chronic viral hepatitis. BMC Gastroenterol 2022;22:508. [PMID: 36494622 DOI: 10.1186/s12876-022-02570-w] [Reference Citation Analysis]
|
| 6 |
He X, Liu T, Zhang R, Li X, Sheikh N. Associations between Extracellular Matrix Protein 1 Gene Polymorphism and Progression of Liver Disease. Genetics Research 2022;2022:1-9. [DOI: 10.1155/2022/9304264] [Reference Citation Analysis]
|
| 7 |
Rimal R, Desai P, Daware R, Hosseinnejad A, Prakash J, Lammers T, Singh S. Cancer-associated fibroblasts: Origin, function, imaging, and therapeutic targeting. Adv Drug Deliv Rev 2022;189:114504. [PMID: 35998825 DOI: 10.1016/j.addr.2022.114504] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 8 |
Abou Seada N, El Hamamsy M, Shaheen S, Elwakil R, Barakat A, El‐sayed Mansy A. The impact of clinical pharmacist-led health education on the disease course of non-alcoholic fatty liver disease patients: an interventional study. F1000Res 2022;11:234. [DOI: 10.12688/f1000research.77415.1] [Reference Citation Analysis]
|
| 9 |
Nitta N, Yamakawa M, Hachiya H, Shiina T. A review of physical and engineering factors potentially affecting shear wave elastography. Jpn J Med Ultrasonics 2022. [DOI: 10.3179/jjmu.jjmu.r.209] [Reference Citation Analysis]
|
| 10 |
Bouferraa Y, Haibe Y, Jabra E, Charafeddine M, Kreidieh M, Raad R, Temraz S, Mukherji D, Ershaid F, Muallem N, Faraj W, Khalife M, Eid RA, Shamseddine A. Comparison Between Liver Stiffness Measurement by Fibroscan and Splenic Volume Index as NonInvasive Tools for the Early Detection of Oxaliplatin-induced Hepatotoxicity. J Clin Exp Hepatol 2022;12:448-53. [PMID: 35535062 DOI: 10.1016/j.jceh.2021.06.007] [Reference Citation Analysis]
|
| 11 |
Ong SY, Khoo T, Nicoll AJ, Gurrin L, Worland T, Pateria P, Ramm LE, Testro A, Anderson GJ, Skoien R, Powell LW, Ramm GA, Olynyk JK, Delatycki MB. Utility and limitations of Hepascore and transient elastography to detect advanced hepatic fibrosis in HFE hemochromatosis. Sci Rep 2021;11:14654. [PMID: 34282177 DOI: 10.1038/s41598-021-94083-x] [Reference Citation Analysis]
|
| 12 |
Fu F, Li X, Liu Q, Chen C, Bai Y, Shi D, Sang J, Wang K, Wang M. Noninvasive DW-MRI metrics for staging hepatic fibrosis and grading inflammatory activity in patients with chronic hepatitis B. Abdom Radiol (NY) 2021;46:1864-75. [PMID: 33074424 DOI: 10.1007/s00261-020-02801-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 13 |
Fan N, Wu C, Zhou Y, Wang X, Li P, Liu Z, Tang B. Rapid Two-Photon Fluorescence Imaging of Monoamine Oxidase B for Diagnosis of Early-Stage Liver Fibrosis in Mice. Anal Chem 2021;93:7110-7. [PMID: 33909401 DOI: 10.1021/acs.analchem.1c00815] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 14 |
Vilfranc CL, Che LX, Patra KC, Niu L, Olowokure O, Wang J, Shah SA, Du CY. BIR repeat-containing ubiquitin conjugating enzyme (BRUCE) regulation of β-catenin signaling in the progression of drug-induced hepatic fibrosis and carcinogenesis. World J Hepatol 2021;13:343-61. [PMID: 33815677 DOI: 10.4254/wjh.v13.i3.343] [Reference Citation Analysis]
|
| 15 |
Lan L, Lu X, Shu J. T2 Values for Diagnosing Acute-on-Chronic Liver Failure in Hepatitis B Patients. Curr Med Imaging 2021;17:129-35. [PMID: 32586254 DOI: 10.2174/1573405616666200625152357] [Reference Citation Analysis]
|
| 16 |
Charatcharoenwitthaya P, Sukonrut K, Korpraphong P, Pongpaibul A, Saiviroonporn P. Diffusion-weighted magnetic resonance imaging for the assessment of liver fibrosis in chronic viral hepatitis. PLoS One 2021;16:e0248024. [PMID: 33662022 DOI: 10.1371/journal.pone.0248024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 17 |
Mendoza-avendaño M, Ramírez-carvajal A, Barreto-herrera I, Muñoz-báez K, Ramos-villegas Y, Shrivastava A, Janjua T, Moscote-salazar LR, Agrawal A. Approach to Emergent Neurotrauma-related Neurosurgical Procedures in Patients with Hepatic Disease. Indian Journal of Neurotrauma 2021;18:133-7. [DOI: 10.1055/s-0041-1725215] [Reference Citation Analysis]
|
| 18 |
Wang X, Hu Y, Lu X, Cai Y, Shu J. Quantitative T2 mapping of rats with chronic hepatitis. Exp Ther Med 2021;21:225. [PMID: 33603834 DOI: 10.3892/etm.2021.9656] [Reference Citation Analysis]
|
| 19 |
Pennisi G, Giammanco A, Petta S. The Role of Transient Elastography in NAFLD. Elastography of the Liver and Beyond 2021. [DOI: 10.1007/978-3-030-74132-7_5] [Reference Citation Analysis]
|
| 20 |
Nitta N, Yamakawa M, Hachiya H, Shiina T. A review of physical and engineering factors potentially affecting shear wave elastography. J Med Ultrason (2001) 2021;48:403-14. [PMID: 34453649 DOI: 10.1007/s10396-021-01127-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 21 |
Park EJ, Kim SH, Park SJ, Baek TW. Texture Analysis of Gray-Scale Ultrasound Images for Staging of Hepatic Fibrosis. J Korean Soc Radiol 2021;82:116. [DOI: 10.3348/jksr.2019.0185] [Reference Citation Analysis]
|
| 22 |
Ahmed NAF, Deiab AG, Hasan ASM, Elbaky AMYA. Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals. Egypt Liver Journal 2020;10:41. [DOI: 10.1186/s43066-020-00051-x] [Reference Citation Analysis]
|
| 23 |
Shi MJ, Xiao HM, Xie YB, Jiang JM, Zhao PT, Cai GS, Li YX, Li S, Zhang CZ, Cao ML, Chen QB, Tan ZJ, Gao HJ, Chi XL. Differences in MicroRNA Expression in Chronic Hepatitis B Patients with Early Liver Fibrosis Based on Traditional Chinese Medicine Syndromes. Evid Based Complement Alternat Med 2020;2020:5956940. [PMID: 33178319 DOI: 10.1155/2020/5956940] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 24 |
Bai X, Su G, Zhai S. Recent Advances in Nanomedicine for the Diagnosis and Therapy of Liver Fibrosis. Nanomaterials (Basel) 2020;10:E1945. [PMID: 33003520 DOI: 10.3390/nano10101945] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 25 |
Su TH, Peng CY, Tseng TC, Yang HC, Liu CJ, Liu CH, Chen PJ, Chen DS, Kao JH. Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis. J Infect Dis. 2020;221:589-597. [PMID: 31574141 DOI: 10.1093/infdis/jiz496] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 26 |
Abdelgawad ME, El-Zakzok H, Salah M, El-Mezayen HA. Diagnostic accuracy of hepatocyte growth factor, Fas/CD95 and Endostatin for non-invasive assessment of hepatic fibrosis in biopsy-proven hepatitis C virus patients. Infect Genet Evol 2020;85:104526. [PMID: 32890764 DOI: 10.1016/j.meegid.2020.104526] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 27 |
Zhou B, Shao J, Schaefbauer KJ, Egan AM, Carmona EM, Limper AH, Zhang X. Grading Bleomycin-Induced Pulmonary Fibrosis in ex vivo Mouse Lungs Using Ultrasound Image Analysis. J Ultrasound Med 2021;40:763-70. [PMID: 32865263 DOI: 10.1002/jum.15448] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 28 |
Moon CM, Shin SS, Heo SH, Lim HS, Moon MJ, Surendran SP, Kim GE, Park IW, Jeong YY. Metabolic Changes in Different Stages of Liver Fibrosis: In vivo Hyperpolarized 13C MR Spectroscopy and Metabolic Imaging. Mol Imaging Biol 2019;21:842-51. [PMID: 30693432 DOI: 10.1007/s11307-019-01322-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 29 |
Eren T, Pasaoglu L. Splenomegaly in Colon Cancer During Adjuvant Oxaliplatin-based Chemotherapy. Cureus 2020;12:e7230. [PMID: 32280572 DOI: 10.7759/cureus.7230] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 30 |
Li Z, Hu Y, Wang H, Wang M, Gu X, Ping Y, Zeng Q, Li H, Yan J, Yu Z. Predictors for the progression of hepatic cirrhosis to hepatocellular carcinoma under long-term antiviral therapy. Eur J Gastroenterol Hepatol 2020;32:447-53. [PMID: 32012142 DOI: 10.1097/MEG.0000000000001631] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 31 |
Maev IV, Samsonov AA, Palgova LK, Pavlov CS, Vovk EI, Shirokova EN, Starostin KM. Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study). BMJ Open Gastroenterol 2020;7:e000341. [PMID: 32095253 DOI: 10.1136/bmjgast-2019-000341] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 32 |
Shi MJ, Yan XL, Dong BS, Yang WN, Su SB, Zhang H. A network pharmacology approach to investigating the mechanism of Tanshinone IIA for the treatment of liver fibrosis. J Ethnopharmacol 2020;253:112689. [PMID: 32101775 DOI: 10.1016/j.jep.2020.112689] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 33 |
Melo RCN, Raas MWD, Palazzi C, Neves VH, Malta KK, Silva TP. Whole Slide Imaging and Its Applications to Histopathological Studies of Liver Disorders. Front Med (Lausanne) 2019;6:310. [PMID: 31970160 DOI: 10.3389/fmed.2019.00310] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 34 |
Li B, Yan K, Tai D, Huo Y, Lu L, Xiao J, Harrison AP. Reliable Liver Fibrosis Assessment from Ultrasound Using Global Hetero-Image Fusion and View-Specific Parameterization. Medical Image Computing and Computer Assisted Intervention – MICCAI 2020 2020. [DOI: 10.1007/978-3-030-59716-0_58] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 35 |
Shiha G, Mousa N. Noninvasive Biomarkers for Liver Fibrosis. Liver Diseases 2020. [DOI: 10.1007/978-3-030-24432-3_36] [Reference Citation Analysis]
|
| 36 |
Seo B, Jeon K, Moon S, Lee K, Kim W, Jeong H, Cha KH, Lim MY, Kang W, Kweon M, Sung J, Kim W, Park J, Ko G. Roseburia spp. Abundance Associates with Alcohol Consumption in Humans and Its Administration Ameliorates Alcoholic Fatty Liver in Mice. Cell Host & Microbe 2020;27:25-40.e6. [DOI: 10.1016/j.chom.2019.11.001] [Cited by in Crossref: 65] [Cited by in F6Publishing: 71] [Article Influence: 21.7] [Reference Citation Analysis]
|
| 37 |
Wang B, Wei J, Meng L, Wang H, Qu C, Chen X, Xin Y, Jiang X. Advances in pathogenic mechanisms and management of radiation-induced fibrosis. Biomedicine & Pharmacotherapy 2020;121:109560. [DOI: 10.1016/j.biopha.2019.109560] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 38 |
Lu QQ, Chen M, Wang XL, Cao SQ. Meta-analysis of diagnostic value of circulating microRNAs in hepatitis B-related fibrosis. Shijie Huaren Xiaohua Zazhi 2019; 27(22): 1365-1374 [DOI: 10.11569/wcjd.v27.i22.1365] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 39 |
Sharafi A, Baboli R, Zibetti M, Shanbhogue K, Olsen S, Block T, Chandarana H, Regatte R. Volumetric multicomponent T1ρ relaxation mapping of the human liver under free breathing at 3T. Magn Reson Med 2020;83:2042-50. [PMID: 31724246 DOI: 10.1002/mrm.28061] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 40 |
Chalouni M, Sogni P, Miailhes P, Lacombe K, Poizot-Martin I, Chas J, Vittecoq D, Neau D, Aumaitre H, Alric L, Piroth L, Bouchaud O, Katlama C, Morlat P, Lascoux-Combe C, Gervais A, Naqvi A, Rosenthal E, Garipuy D, Barange K, Esterle L, Salmon D, Wittkop L; ANRS CO13 HEPAVIH study group. Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort. Eur J Gastroenterol Hepatol 2019;31:1387-96. [PMID: 31033848 DOI: 10.1097/MEG.0000000000001408] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 41 |
Allocca M, Fiorino G, Bonifacio C, Peyrin-Biroulet L, Danese S. Noninvasive Multimodal Methods to Differentiate Inflamed vs Fibrotic Strictures in Patients With Crohn's Disease. Clin Gastroenterol Hepatol 2019;17:2397-415. [PMID: 30995529 DOI: 10.1016/j.cgh.2019.04.025] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 42 |
Federico A, Dallio M, Masarone M, Gravina AG, Di Sarno R, Tuccillo C, Cossiga V, Lama S, Stiuso P, Morisco F, Persico M, Loguercio C. Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients. Oxid Med Cell Longev 2019;2019:8742075. [PMID: 31737175 DOI: 10.1155/2019/8742075] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 43 |
Lee JH, Joo I, Kang TW, Paik YH, Sinn DH, Ha SY, Kim K, Choi C, Lee G, Yi J, Bang WC. Deep learning with ultrasonography: automated classification of liver fibrosis using a deep convolutional neural network. Eur Radiol 2020;30:1264-73. [PMID: 31478087 DOI: 10.1007/s00330-019-06407-1] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 44 |
Gressner AM, Gressner OA. Elastographie, transiente. Springer Reference Medizin 2019. [DOI: 10.1007/978-3-662-48986-4_979] [Reference Citation Analysis]
|
| 45 |
Nielsen MJ, Karsdal MA, Krag A, Leeming DJ. Extracellular Matrix Remodeling with Focus on Biochemical Markers in Liver Fibrosis: Limitations and Possibilities. The Human Gut-Liver-Axis in Health and Disease 2019. [DOI: 10.1007/978-3-319-98890-0_15] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 46 |
Kessler E, Hassoun E. Procollagen C-Proteinase Enhancer 1 (PCPE-1) in Liver Fibrosis. Methods Mol Biol 2019;1944:189-201. [PMID: 30840244 DOI: 10.1007/978-1-4939-9095-5_14] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 47 |
Zawada E, Serafin Z, Dybowska D, Halota W, Wypych A, Nadolska K, Rusak G. Monoexponential and Biexponential Fitting of Diffusional Magnetic Resonance Imaging Signal Analysis for Prediction of Liver Fibrosis Severity: . Journal of Computer Assisted Tomography 2019;43:857-62. [DOI: 10.1097/rct.0000000000000937] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 48 |
Dazley J, Szabela E, Adebara A, Shukla P, Sison R, Slim J. The Largest American Study Comparing Transient Elastography and the Aminotransferase-to-platelet Ratio Index Score, Two Noninvasive Tests for Liver Fibrosis Staging in HIV/HCV Coinfected Patients. J Glob Infect Dis 2019;11:80-2. [PMID: 31198312 DOI: 10.4103/jgid.jgid_10_16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 49 |
Athwal VS, Pritchett J, Martin K, Llewellyn J, Scott J, Harvey E, Zaitoun AM, Mullan AF, Zeef LAH, Friedman SL, Irving WL, Hanley NA, Guha IN, Piper Hanley K. SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosis. Sci Rep 2018;8:17905. [PMID: 30559459 DOI: 10.1038/s41598-018-36037-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 50 |
Amarneh M, Akhter A, Rajput MZ, LaBrecque DR, Abu-Yousef M. Gallbladder Scalloping, Mammillated Caudate Lobe, and Inferior Vena Cava Scalloping: Three Novel Ultrasound Signs of Cirrhosis. Acad Radiol 2018;25:1374-80. [PMID: 29602725 DOI: 10.1016/j.acra.2018.02.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 51 |
Luo Y, Oseini A, Gagnon R, Charles ED, Sidik K, Vincent R, Collen R, Idowu M, Contos MJ, Mirshahi F, Daita K, Asgharpour A, Siddiqui MS, Jarai G, Rosen G, Christian R, Sanyal AJ. An Evaluation of the Collagen Fragments Related to Fibrogenesis and Fibrolysis in Nonalcoholic Steatohepatitis. Sci Rep. 2018;8:12414. [PMID: 30120271 DOI: 10.1038/s41598-018-30457-y] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 52 |
Golfeyz S, Lewis S, Weisberg IS. Hemochromatosis: pathophysiology, evaluation, and management of hepatic iron overload with a focus on MRI. Expert Rev Gastroenterol Hepatol 2018;12:767-78. [PMID: 29966105 DOI: 10.1080/17474124.2018.1496016] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 53 |
Su T, Liao C, Liu C, Huang K, Tseng T, Yang H, Liu C, Chen P, Chen D, Kao J. Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral Therapy. Radiology 2018;288:293-9. [DOI: 10.1148/radiol.2018171116] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 54 |
Armstrong T, Ly KV, Murthy S, Ghahremani S, Kim GHJ, Calkins KL, Wu HH. Free-breathing quantification of hepatic fat in healthy children and children with nonalcoholic fatty liver disease using a multi-echo 3-D stack-of-radial MRI technique. Pediatr Radiol 2018;48:941-53. [PMID: 29728744 DOI: 10.1007/s00247-018-4127-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 55 |
Weiskirchen R, Weiskirchen S, Tacke F. Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications. Mol Aspects Med 2019;65:2-15. [PMID: 29958900 DOI: 10.1016/j.mam.2018.06.003] [Cited by in Crossref: 217] [Cited by in F6Publishing: 239] [Article Influence: 43.4] [Reference Citation Analysis]
|
| 56 |
Valva P, Rios D, Casciato P, Gadano A, Galdame O, Mullen E, Bertot G, de Matteo E, Preciado MV. Nonalcoholic fatty liver disease: biomarkers as diagnostic tools for liver damage assessment in adult patients from Argentina. Eur J Gastroenterol Hepatol 2018;30:637-44. [PMID: 29384795 DOI: 10.1097/MEG.0000000000001079] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 57 |
Arsik I, Frediani JK, Frezza D, Chen W, Ayer T, Keskinocak P, Jin R, Konomi JV, Barlow SE, Xanthakos SA, Lavine JE, Vos MB. Alanine Aminotransferase as a Monitoring Biomarker in Children with Nonalcoholic Fatty Liver Disease: A Secondary Analysis Using TONIC Trial Data. Children (Basel) 2018;5:E64. [PMID: 29799476 DOI: 10.3390/children5060064] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 58 |
Erman A, Sathya A, Nam A, Bielecki JM, Feld JJ, Thein HH, Wong WWL, Grootendorst P, Krahn MD. Estimating chronic hepatitis C prognosis using transient elastography-based liver stiffness: A systematic review and meta-analysis. J Viral Hepat 2018;25:502-13. [PMID: 29239068 DOI: 10.1111/jvh.12846] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 59 |
Dong H, Xu C, Zhou W, Liao Y, Cao J, Li Z, Hu B. The combination of 5 serum markers compared to FibroScan to predict significant liver fibrosis in patients with chronic hepatitis B virus. Clin Chim Acta. 2018;483:145-150. [PMID: 29709450 DOI: 10.1016/j.cca.2018.04.036] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 60 |
Kim TH, Yang HK, Jang HJ, Yoo SJ, Khalili K, Kim TK. Abdominal imaging findings in adult patients with Fontan circulation. Insights Imaging 2018;9:357-67. [PMID: 29623675 DOI: 10.1007/s13244-018-0609-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 61 |
Imanzadeh F, Dara N, Rohani P, Emadi B, Sanii S, Mousavi - Khorshidi M, Hosseini AH. Validation of Aspartate Aminotransferase to Platelet Ratio for Diagnosis of Hepatic Fibrosis and Prognostic Prediction of Infants with Biliary Atresia after Portoenterostomy. J Compr Ped 2018;9. [DOI: 10.5812/compreped.13304] [Reference Citation Analysis]
|
| 62 |
Zhang D, Zhuang R, Guo Z, Gao M, Huang L, You L, Zhang P, Li J, Su X, Wu H, Chen X, Zhang X. Desmin- and vimentin-mediated hepatic stellate cell-targeting radiotracer 99mTc-GlcNAc-PEI for liver fibrosis imaging with SPECT. Theranostics 2018;8:1340-9. [PMID: 29507624 DOI: 10.7150/thno.22806] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 63 |
Song KH, Lee MY, Yoo CH, Lim SI, Choe BY. Improved quantitative fatty acid values with correction of T2 relaxation time in terminal methyl group: In vivo proton magnetic resonance spectroscopy at ultra high field in hepatic steatosis. Chem Phys Lipids 2018;212:35-43. [PMID: 29337015 DOI: 10.1016/j.chemphyslip.2018.01.004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 64 |
Kwee SA, Wong L, Chan OTM, Kalathil S, Tsai N. PET/CT with 18F Fluorocholine as an Imaging Biomarker for Chronic Liver Disease: A Preliminary Radiopathologic Correspondence Study in Patients with Liver Cancer. Radiology 2018;287:294-302. [PMID: 29315063 DOI: 10.1148/radiol.2018171333] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 65 |
Bang CS, Kang HY, Choi GH, Kim SB, Lee W, Song IH. The Performance of Serum Biomarkers for Predicting Fibrosis in Patients with Chronic Viral Hepatitis. Korean J Gastroenterol 2017;69:298-307. [PMID: 28539035 DOI: 10.4166/kjg.2017.69.5.298] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 66 |
Guido M. Regression of Liver Fibrosis. Practical Hepatic Pathology: a Diagnostic Approach 2018. [DOI: 10.1016/b978-0-323-42873-6.00040-8] [Reference Citation Analysis]
|
| 67 |
Bedossa P, Paradis V, Zucman-rossi J. Cellular and Molecular Techniques. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 88-110. [DOI: 10.1016/b978-0-7020-6697-9.00002-9] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 68 |
Axley P, Mudumbi S, Sarker S, Kuo YF, Singal AK. Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications. PLoS One 2018;13:e0197117. [PMID: 29746540 DOI: 10.1371/journal.pone.0197117] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 69 |
Habib S, Shaikh OS. Approach to Jaundice and Abnormal Liver Function Test Results. Zakim and Boyer's Hepatology 2018. [DOI: 10.1016/b978-0-323-37591-7.00007-0] [Reference Citation Analysis]
|
| 70 |
Xiao H, Shi M, Xie Y, Chi X. Comparison of diagnostic accuracy of magnetic resonance elastography and Fibroscan for detecting liver fibrosis in chronic hepatitis B patients: A systematic review and meta-analysis. PLoS One 2017;12:e0186660. [PMID: 29107943 DOI: 10.1371/journal.pone.0186660] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 71 |
Berzigotti A, França M, Martí-aguado D, Martí-bonmatí L. Cuantificación de la fibrosis hepática mediante biomarcadores de imagen. Radiología 2018;60:74-84. [DOI: 10.1016/j.rx.2017.09.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 72 |
Baues M, Dasgupta A, Ehling J, Prakash J, Boor P, Tacke F, Kiessling F, Lammers T. Fibrosis imaging: Current concepts and future directions. Adv Drug Deliv Rev 2017;121:9-26. [PMID: 29108860 DOI: 10.1016/j.addr.2017.10.013] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 73 |
Curry MP, Jeffers LJ. Laboratory Tests, Noninvasive Markers of Fibrosis, Liver Biopsy, and Laparoscopy. Schiff's Diseases of the Liver 2017. [DOI: 10.1002/9781119251316.ch2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 74 |
Kimura K, Ikoma A, Shibakawa M, Shimoda S, Harada K, Saio M, Imamura J, Osawa Y, Kimura M, Nishikawa K, Okusaka T, Morita S, Inoue K, Kanto T, Todaka K, Nakanishi Y, Kohara M, Mizokami M. Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial. EBioMedicine 2017;23:79-87. [PMID: 28844410 DOI: 10.1016/j.ebiom.2017.08.016] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 9.2] [Reference Citation Analysis]
|
| 75 |
Liang XE, Chen YP. Clinical Application of Vibration Controlled Transient Elastography in Patients with Chronic Hepatitis B. J Clin Transl Hepatol 2017;5:368-75. [PMID: 29226103 DOI: 10.14218/JCTH.2017.00006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 76 |
Guo Y, Liang X, Meng M, Chen H, Wei X, Li M, Li J, Huang R, Wei J. Hepatoprotective effects of Yulangsan flavone against carbon tetrachloride (CCl4)-induced hepatic fibrosis in rats. Phytomedicine 2017;33:28-35. [PMID: 28887917 DOI: 10.1016/j.phymed.2017.07.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 77 |
Wong S, Huynh D, Zhang F, Nguyen NQ. Use of aspartate aminotransferase to platelet ratio to reduce the need for FibroScan in the evaluation of liver fibrosis. World J Hepatol 2017;9:791-6. [PMID: 28660013 DOI: 10.4254/wjh.v9.i17.791] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 78 |
Chen HH, Waghorn PA, Wei L, Tapias LF, Schühle DT, Rotile NJ, Jones CM, Looby RJ, Zhao G, Elliott JM, Probst CK, Mino-Kenudson M, Lauwers GY, Tager AM, Tanabe KK, Lanuti M, Fuchs BC, Caravan P. Molecular imaging of oxidized collagen quantifies pulmonary and hepatic fibrogenesis. JCI Insight 2017;2:91506. [PMID: 28570270 DOI: 10.1172/jci.insight.91506] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 79 |
Aubé C, Bazeries P, Lebigot J, Cartier V, Boursier J. Liver fibrosis, cirrhosis, and cirrhosis-related nodules: Imaging diagnosis and surveillance. Diagnostic and Interventional Imaging 2017;98:455-68. [DOI: 10.1016/j.diii.2017.03.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 80 |
Sato K, Chayama K, Alves K, Toyoda H, Suzuki F, Kato K, Rodrigues L Jr, Zhang X, Setze C, Pilot-Matias T, Burroughs M, Redman R, Kumada H. Randomized Phase 3 Trial of Ombitasvir/Paritaprevir/Ritonavir and Ribavirin for Hepatitis C Virus Genotype 2-Infected Japanese Patients. Adv Ther 2017;34:1449-65. [PMID: 28536999 DOI: 10.1007/s12325-017-0506-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 81 |
Zhu B, Wei L, Rotile N, Day H, Rietz T, Farrar CT, Lauwers GY, Tanabe KK, Rosen B, Fuchs BC, Caravan P. Combined magnetic resonance elastography and collagen molecular magnetic resonance imaging accurately stage liver fibrosis in a rat model. Hepatology 2017;65:1015-25. [PMID: 28039886 DOI: 10.1002/hep.28930] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 82 |
Mare R, Sporea I, Lupuşoru R, Şirli R, Popescu A, Danila M, Pienar C. The value of ElastPQ for the evaluation of liver stiffness in patients with B and C chronic hepatopathies. Ultrasonics 2017;77:144-51. [PMID: 28231488 DOI: 10.1016/j.ultras.2017.02.005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 83 |
Calame P, Ronot M, Bouveresse S, Cervoni J, Vilgrain V, Delabrousse É. Predictive value of CT for first esophageal variceal bleeding in patients with cirrhosis: Value of para-umbilical vein patency. European Journal of Radiology 2017;87:45-52. [DOI: 10.1016/j.ejrad.2016.12.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 84 |
Gressner AM, Gressner OA. Elastographie, transiente. Lexikon der Medizinischen Laboratoriumsdiagnostik 2017. [DOI: 10.1007/978-3-662-49054-9_979-1] [Reference Citation Analysis]
|
| 85 |
Nielsen MJ, Leeming DJ, Karsdal MA, Krag A. Biomarkers of Extracellular Matrix Remodeling in Liver Diseases. Biomarkers in Disease: Methods, Discoveries and Applications 2017. [DOI: 10.1007/978-94-007-7675-3_14] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 86 |
Liu J, Zhao J, Zhang Y, Ji Y, Lin S, Dun G, Guo S. Noninvasive Assessment of Liver Fibrosis Stage Using Ultrasound-Based Shear Wave Velocity Measurements and Serum Algorithms in Patients With Viral Hepatitis B: A Retrospective Cohort Study. J Ultrasound Med. 2017;36:285-293. [PMID: 28039877 DOI: 10.7863/ultra.16.01069] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 87 |
Karanjia RN, Crossey MME, Cox IJ, Fye HKS, Njie R, Goldin RD, Taylor-Robinson SD. Hepatic steatosis and fibrosis: Non-invasive assessment. World J Gastroenterol 2016; 22(45): 9880-9897 [PMID: 28018096 DOI: 10.3748/wjg.v22.i45.9880] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 45] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 88 |
Hernández-Bartolomé A, López-Rodríguez R, Borque MJ, González-Moreno L, Real-Martínez Y, García-Buey L, Moreno-Otero R, Sanz-Cameno P. Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C. World J Gastroenterol 2016; 22(44): 9744-9751 [PMID: 27956798 DOI: 10.3748/wjg.v22.i44.9744] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 89 |
Sugimoto M, Oka H, Kajihama A, Nakau K, Kuwata S, Kurishima C, Azuma H. Non-invasive assessment of liver fibrosis by magnetic resonance elastography in patients with congenital heart disease undergoing the Fontan procedure and intracardiac repair. Journal of Cardiology 2016;68:202-8. [DOI: 10.1016/j.jjcc.2016.05.016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 90 |
Li F, Yan H, Wang J, Li C, Wu J, Wu S, Rao S, Gao X, Jin Q. Non-invasively differentiating extent of liver fibrosis by visualizing hepatic integrin αvβ3 expression with an MRI modality in mice. Biomaterials 2016;102:162-74. [DOI: 10.1016/j.biomaterials.2016.06.026] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 91 |
Zhang H, Yang Q, Yu T, Chen X, Huang J, Tan C, Liang B, Guo H. Comparison of T2, T1rho, and diffusion metrics in assessment of liver fibrosis in rats. J Magn Reson Imaging 2017;45:741-50. [PMID: 27527587 DOI: 10.1002/jmri.25424] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 92 |
Mendes LC, Ferreira PA, Miotto N, Zanaga L, Gonçales E, Lazarini MS, Gonçales FL Júnior, Stucchi RS, Vigani AG. Transient elastography and APRI score: looking at false positives and false negatives. Diagnostic performance and association to fibrosis staging in chronic hepatitis C. Braz J Med Biol Res 2016;49:e5432. [PMID: 27533769 DOI: 10.1590/1414-431X20165432] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 93 |
Toson el-SA, Shiha GE, El-Mezayen HA, El-Sharkawy AM. Diagnostic performance of T lymphocyte subpopulations in assessment of liver fibrosis stages in hepatitis C virus patients: simple noninvasive score. Eur J Gastroenterol Hepatol 2016;28:931-9. [PMID: 27159125 DOI: 10.1097/MEG.0000000000000656] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 94 |
Hassoun E, Safrin M, Ziv H, Pri-Chen S, Kessler E. Procollagen C-Proteinase Enhancer 1 (PCPE-1) as a Plasma Marker of Muscle and Liver Fibrosis in Mice. PLoS One 2016;11:e0159606. [PMID: 27458976 DOI: 10.1371/journal.pone.0159606] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 95 |
Jang CH, Kim KM, Yang JH, Cho SS, Kim SJ, Shin SM, Cho IJ, Ki SH. The Role of Lipin-1 in the Regulation of Fibrogenesis and TGF-β Signaling in Hepatic Stellate Cells. Toxicol Sci 2016;153:28-38. [PMID: 27345520 DOI: 10.1093/toxsci/kfw109] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 96 |
Wang M, Liu R, Liang Y, Yang G, Huang Y, Yu C, Sun K, Lai Y, Xia Y. Iron overload correlates with serum liver fibrotic markers and liver dysfunction: Potential new methods to predict iron overload-related liver fibrosis in thalassemia patients. United European Gastroenterol J 2017;5:94-103. [PMID: 28405327 DOI: 10.1177/2050640616646525] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 97 |
Guimaraes AR, Siqueira L, Uppal R, Alford J, Fuchs BC, Yamada S, Tanabe K, Chung RT, Lauwers G, Chew ML, Boland GW, Sahani DV, Vangel M, Hahn PF, Caravan P. T2 relaxation time is related to liver fibrosis severity. Quant Imaging Med Surg 2016;6:103-14. [PMID: 27190762 DOI: 10.21037/qims.2016.03.02] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 98 |
Zhang D, Guo Z, Zhang P, Li Y, Su X, You L, Gao M, Liu C, Wu H, Zhang X. Simplified quantification method for in vivo SPECT/CT imaging of asialoglycoprotein receptor with (99m)Tc-p(VLA-co-VNI) to assess and stage hepatic fibrosis in mice. Sci Rep. 2016;6:25377. [PMID: 27150943 DOI: 10.1038/srep25377] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 99 |
Yang Q, Yu T, Yun S, Zhang H, Chen X, Cheng Z, Zhong J, Huang J, Okuaki T, Chan Q, Liang B, Guo H. Comparison of multislice breath-hold and 3D respiratory triggered T1 ρ imaging of liver in healthy volunteers and liver cirrhosis patients in 3.0 T MRI: Comparison of Different T1 ρ Imaging Sequences. J Magn Reson Imaging 2016;44:906-13. [DOI: 10.1002/jmri.25253] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 100 |
Kaswala DH, Lai M, Afdhal NH. Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016. Dig Dis Sci 2016;61:1356-64. [PMID: 27017224 DOI: 10.1007/s10620-016-4079-4] [Cited by in Crossref: 95] [Cited by in F6Publishing: 96] [Article Influence: 13.6] [Reference Citation Analysis]
|
| 101 |
Liang XE, Dai L, Yang SL, Zhong CX, Peng J, Zhu YF, Chen YP, Hou JL. Combining routine markers improves the accuracy of transient elastography for hepatitis B cirrhosis detection. Dig Liver Dis 2016;48:512-8. [PMID: 26965782 DOI: 10.1016/j.dld.2016.02.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 102 |
Yong KMA, Yu ZTF, Guan KH, Fu J. Types of Clinical Samples and Cellular Enrichment Strategies. Micro- and Nanosystems for Biotechnology 2016. [DOI: 10.1002/9783527801312.ch1] [Reference Citation Analysis]
|
| 103 |
Liu J, Ji Y, Ai H, Ning B, Zhao J, Zhang Y, Dun G. Liver Shear-Wave Velocity and Serum Fibrosis Markers to Diagnose Hepatic Fibrosis in Patients with Chronic Viral Hepatitis B. Korean J Radiol. 2016;17:396-404. [PMID: 27134527 DOI: 10.3348/kjr.2016.17.3.396] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 104 |
Tama M, Naylor P, Patel S, Altawil J, Gulati D, Antaki F, Mutchnick MG, Ehrinpreis M. Overestimate of Fibrosis by FIBROSpect® II in African Americans Complicates the Management of their Chronic Hepatitis C. J Clin Transl Hepatol 2016;4:12-9. [PMID: 27047767 DOI: 10.14218/JCTH.2015.00053] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 105 |
Josephus Jitta D, Wagenaar LJ, Mulder BJ, Guichelaar M, Bouman D, van Melle JP. Three cases of hepatocellular carcinoma in Fontan patients: Review of the literature and suggestions for hepatic screening. International Journal of Cardiology 2016;206:21-6. [DOI: 10.1016/j.ijcard.2015.12.033] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 106 |
Cobbold JFL, Taylor-robinson SD. Are the advantages of obtaining a liver biopsy outweighed by the disadvantages? Clinical Dilemmas in Non-Alcoholic Fatty Liver Disease 2016. [DOI: 10.1002/9781118924938.ch17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 107 |
Eslam M, Hashem AM, Romero-Gomez M, Berg T, Dore GJ, Mangia A, Chan HLY, Irving WL, Sheridan D, Abate ML, Adams LA, Weltman M, Bugianesi E, Spengler U, Shaker O, Fischer J, Mollison L, Cheng W, Nattermann J, Riordan S, Miele L, Kelaeng KS, Ampuero J, Ahlenstiel G, McLeod D, Powell E, Liddle C, Douglas MW, Booth DR, George J; International Liver Disease Genetics Consortium (ILDGC). FibroGENE: A gene-based model for staging liver fibrosis. J Hepatol 2016;64:390-8. [PMID: 26592354 DOI: 10.1016/j.jhep.2015.11.008] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 108 |
Valva P, Ríos DA, De Matteo E, Preciado MV. Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage. World J Gastroenterol 2016; 22(4): 1367-1381 [PMID: 26819506 DOI: 10.3748/wjg.v22.i4.1367] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 109 |
Wang Y, Hou J. Fibrosis assessment: impact on current management of chronic liver disease and application of quantitative invasive tools. Hepatol Int 2016;10:448-61. [DOI: 10.1007/s12072-015-9695-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 110 |
Park S, Kim HY, Kim H, Park JH, Kim JH, Kim KH, Kim W, Choi IS, Jung YJ, Kim JS. Changes in Noninvasive Liver Fibrosis Indices and Spleen Size During Chemotherapy: Potential Markers for Oxaliplatin-Induced Sinusoidal Obstruction Syndrome. Medicine (Baltimore) 2016;95:e2454. [PMID: 26765438 DOI: 10.1097/MD.0000000000002454] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 111 |
Guo Y, Parthasarathy S, Goyal P, McCarthy RJ, Larson AC, Miller FH. Magnetic resonance elastography and acoustic radiation force impulse for staging hepatic fibrosis: a meta-analysis. Abdom Imaging. 2015;40:818-834. [PMID: 24711064 DOI: 10.1007/s00261-014-0137-6] [Cited by in Crossref: 58] [Cited by in F6Publishing: 67] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 112 |
Zhuravlyova A, Kharkiv National Medical University, Ogneva O, Kharkiv National Medical University.. Modern possibilities of diagnosis and quantification of liver fibrosis. Shidnoevr z vnutr simejnoi med 2015;2015:55-60. [DOI: 10.15407/internalmed2015.02.055] [Reference Citation Analysis]
|
| 113 |
Chung SR, Lee SS, Kim N, Yu ES, Kim E, Kühn B, Kim IS. Intravoxel incoherent motion MRI for liver fibrosis assessment: a pilot study. Acta Radiol 2015;56:1428-36. [PMID: 25414372 DOI: 10.1177/0284185114559763] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 114 |
Trovato FM, Tognarelli JM, Crossey MM, Catalano D, Taylor-Robinson SD, Trovato GM. Challenges of liver cancer: Future emerging tools in imaging and urinary biomarkers. World J Hepatol 2015;7:2664-75. [PMID: 26609343 DOI: 10.4254/wjh.v7.i26.2664] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 115 |
Oztas E, Kuzu UB, Zengin NI, Kalkan IH, Saygili F, Yildiz H, Celik HT, Akdogan M, Kilic MY, Koksal AS, Odemis B, Suna N, Kayacetin E. Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection? Medicine (Baltimore) 2015;94:e1889. [PMID: 26632683 DOI: 10.1097/MD.0000000000001889] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 116 |
Hanai T, Shiraki M, Ohnishi S, Miyazaki T, Ideta T, Kochi T, Imai K, Suetsugu A, Takai K, Shimizu M, Moriwaki H. Impact of serum glycosylated Wisteria floribunda agglutinin positive Mac-2 binding protein levels on liver functional reserves and mortality in patients with liver cirrhosis. Hepatol Res 2015;45:1083-90. [PMID: 25565570 DOI: 10.1111/hepr.12473] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 117 |
Sagnelli C, Martini S, Pisaturo M, Pasquale G, Macera M, Zampino R, Coppola N, Sagnelli E. Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact. World J Hepatol 2015;7:2510-21. [PMID: 26523204 DOI: 10.4254/wjh.v7.i24.2510] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 118 |
Andrés-otero MJ, Lou-bonafonte JM, Escanero-marcén J, Serrano-aulló T, Puente-lanzarote JJ. Biomarcadores, índices y algoritmos para el diagnóstico de fibrosis hepática en pacientes con hepatitis crónica por virus C. Revista del Laboratorio Clínico 2015;8:179-187. [DOI: 10.1016/j.labcli.2015.07.004] [Reference Citation Analysis]
|
| 119 |
Song K, Baek H, Lee D, Choe B. In vivo proton magnetic resonance spectroscopy of liver metabolites in non-alcoholic fatty liver disease in rats: T2 relaxation times in methylene protons. Chemistry and Physics of Lipids 2015;191:1-7. [DOI: 10.1016/j.chemphyslip.2015.07.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 120 |
Petta S, Maida M, Macaluso FS, Di Marco V, Cammà C, Cabibi D, Craxì A. The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease. Hepatology 2015;62:1101-10. [PMID: 25991038 DOI: 10.1002/hep.27844] [Cited by in Crossref: 159] [Cited by in F6Publishing: 166] [Article Influence: 19.9] [Reference Citation Analysis]
|
| 121 |
Nielsen MJ, Kazankov K, Leeming DJ, Karsdal MA, Krag A, Barrera F, McLeod D, George J, Grønbæk H. Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients. PLoS One 2015;10:e0137302. [PMID: 26406331 DOI: 10.1371/journal.pone.0137302] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 122 |
Reddy N, Naylor P, Hakim Z, Asbahi R, Ravindran K, May E, Ehrinpreis M, Mutchnick M. Effect of Treatment for CHC on Liver Disease Progression and Hepatocellular Carcinoma Development in African Americans. J Clin Transl Hepatol. 2015;3:163-168. [PMID: 26623262 DOI: 10.14218/jcth.2015.00013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 123 |
Trovato FM, Atzori S, Musumeci G, Tooley V, Marcinkowski H, Crossey MM, Ladep NG, Martines GF, Goldin RD, Taylor-Robinson SD. Liver and spleen transient elastography and Acoustic Radiation Force Impulse Measurements. Performance and comparison of measurements in the same area concurrently assessed for liver fibrosis by biopsy. Adv Med Sci 2015;60:300-6. [PMID: 26143473 DOI: 10.1016/j.advms.2015.06.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 124 |
Lapalus M, Laouenan C, Cardoso AC, Estrabaud E, Carvalho-Filho RJ, Zhang Q, Lada O, Appourchaux K, Mouri F, Boyer N, Bedossa P, Asselah T, Martinot-Peignoux M, Marcellin P. Precore/Core promoter variants to predict significant fibrosis in both HBeAg positive and negative chronic hepatitis B. Liver Int 2015;35:2082-9. [PMID: 25612083 DOI: 10.1111/liv.12787] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 125 |
Yokoo T, Wolfson T, Iwaisako K, Peterson MR, Mani H, Goodman Z, Changchien C, Middleton MS, Gamst AC, Mazhar SM, Kono Y, Ho SB, Sirlin CB. Evaluation of Liver Fibrosis Using Texture Analysis on Combined-Contrast-Enhanced Magnetic Resonance Images at 3.0T. Biomed Res Int 2015;2015:387653. [PMID: 26421287 DOI: 10.1155/2015/387653] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 126 |
Wang Y, Hou JL. Current strategies for quantitating fibrosis in liver biopsy. Chin Med J (Engl) 2015;128:252-8. [PMID: 25591571 DOI: 10.4103/0366-6999.149223] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 127 |
Ong SY, Dolling L, Dixon JL, Nicoll AJ, Gurrin LC, Wolthuizen M, Wood EM, Anderson GJ, Ramm GA, Allen KJ, Olynyk JK, Crawford D, Kava J, Ramm LE, Gow P, Durrant S, Powell LW, Delatycki MB. Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron). BMJ Open 2015;5:e008938. [PMID: 26270952 DOI: 10.1136/bmjopen-2015-008938] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 128 |
Gaia S, Campion D, Evangelista A, Spandre M, Cosso L, Brunello F, Ciccone G, Bugianesi E, Rizzetto M. Non-invasive score system for fibrosis in chronic hepatitis: proposal for a model based on biochemical, FibroScan and ultrasound data. Liver Int 2015;35:2027-35. [PMID: 25495478 DOI: 10.1111/liv.12761] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 129 |
Bedossa P, Patel K, Castera L. Histologic and noninvasive estimates of liver fibrosis. Clin Liver Dis (Hoboken) 2015;6:5-8. [PMID: 31040975 DOI: 10.1002/cld.481] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 130 |
Picó Aliaga S, Muro Velilla D, García-martí G, Sangüesa Nebot C, Martí-bonmatí L. La elastografía mediante técnica Acoustic radiation force impulse es eficaz en la detección de fibrosis hepática en el niño. Radiología 2015;57:314-20. [DOI: 10.1016/j.rx.2014.04.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 131 |
Picó Aliaga S, Muro Velilla D, García-martí G, Sangüesa Nebot C, Martí-bonmatí L. Acoustic radiation force impulse imaging elastography is efficacious in detecting hepatic fibrosis in children. Radiología (English Edition) 2015;57:314-320. [DOI: 10.1016/j.rxeng.2014.04.008] [Reference Citation Analysis]
|
| 132 |
Yang LY, Fu J, Peng XF, Pang SY, Gao KK, Chen ZR, He LJ, Wen Z, Wang H, Li L, Wang FH, Yu JK, Xu Y, Gong ST, Xia HM, Liu HY. Validation of aspartate aminotransferase to platelet ratio for diagnosis of liver fibrosis and prediction of postoperative prognosis in infants with biliary atresia. World J Gastroenterol 2015; 21(19): 5893-5900 [PMID: 26019453 DOI: 10.3748/wjg.v21.i19.5893] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 133 |
Park SH, Bang CS, Kim DJ. Biomarkers in HCV Infection. Adv Clin Chem 2015;70:131-96. [PMID: 26231487 DOI: 10.1016/bs.acc.2015.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 134 |
Suk KT, Kim DJ. Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement. World J Hepatol 2015;7:607-15. [PMID: 25848485 DOI: 10.4254/wjh.v7.i3.607] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 135 |
Wu Z, Matsui O, Kitao A, Kozaka K, Koda W, Kobayashi S, Ryu Y, Minami T, Sanada J, Gabata T. Hepatitis C related chronic liver cirrhosis: feasibility of texture analysis of MR images for classification of fibrosis stage and necroinflammatory activity grade. PLoS One. 2015;10:e0118297. [PMID: 25742285 DOI: 10.1371/journal.pone.0118297] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 136 |
Nassef YE, Shady MM, Galal EM, Hamed MA. Performance of diagnostic biomarkers in predicting liver fibrosis among hepatitis C virus-infected Egyptian children. Mem Inst Oswaldo Cruz 2013;108:887-93. [PMID: 24141960 DOI: 10.1590/0074-0276130139] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 137 |
Nielsen MJ, Veidal SS, Karsdal MA, Ørsnes-Leeming DJ, Vainer B, Gardner SD, Hamatake R, Goodman ZD, Schuppan D, Patel K. Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C. Liver Int 2015;35:429-37. [PMID: 25308921 DOI: 10.1111/liv.12700] [Cited by in Crossref: 97] [Cited by in F6Publishing: 100] [Article Influence: 12.1] [Reference Citation Analysis]
|
| 138 |
Marcellin P, Grotzinger K, Theodore D, Demuth D, Manns M, Bañares Cañizares R, Pike J, Forssen UM. Severity of liver disease among chronic hepatitis C patients: an observational study of 4594 patients in five European countries. J Gastroenterol Hepatol 2015;30:364-71. [PMID: 25088088 DOI: 10.1111/jgh.12698] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 139 |
Aubé C. Imaging modalities for the diagnosis of hepatic fibrosis and cirrhosis. Clin Res Hepatol Gastroenterol 2015;39:38-44. [PMID: 25037179 DOI: 10.1016/j.clinre.2014.06.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 140 |
Nielsen MJ, Leeming DJ, Karsdal MA, Krag A. Biomarkers of Extracellular Matrix Remodeling in Liver Diseases. Biomarkers in Disease: Methods, Discoveries and Applications 2015. [DOI: 10.1007/978-94-007-7742-2_14-1] [Reference Citation Analysis]
|
| 141 |
Fujimoto K, Higashi T, Yamada Y, Yamamoto K, Kato M. Noninvasive evaluation of liver fibrosis using real-time tissue elastography. Jpn J Med Ultrasonics 2015;42:487-504. [DOI: 10.3179/jjmu.jjmu.r.48] [Reference Citation Analysis]
|
| 142 |
Lu YP, Wei J, Xu LR, Tang YY, Yuan Y, Zhang Y, Li YY. Assessment of fibrosis during the development of fatty liver in rabbits using real-time shear-wave elastography. J Huazhong Univ Sci Technolog Med Sci 2014;34:921-8. [PMID: 25480592 DOI: 10.1007/s11596-014-1375-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 143 |
Kim H, Park SH, Kim EK, Kim MJ, Park YN, Park HJ, Choi JY. Histogram analysis of gadoxetic acid-enhanced MRI for quantitative hepatic fibrosis measurement. PLoS One. 2014;9:e114224. [PMID: 25460180 DOI: 10.1371/journal.pone.0114224] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 144 |
Lee S, Yu S. Effectiveness Evaluation of the Fat Percentage Determination in Multi-Echo T2-Corrected Single-Voxel Spectroscopy by Comparing the 3-Point Dixon and the 6-Point Interference Dixon Techniques. Appl Magn Reson 2014;45:1333-1342. [DOI: 10.1007/s00723-014-0563-1] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 145 |
Christiansen KM, Mössner BK, Hansen JF, Jarnbjer EF, Pedersen C, Christensen PB. Liver stiffness measurement among patients with chronic hepatitis B and C: results from a 5-year prospective study. PLoS One 2014;9:e111912. [PMID: 25369038 DOI: 10.1371/journal.pone.0111912] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 146 |
Bonder A, Afdhal N. Utilization of FibroScan in clinical practice. Curr Gastroenterol Rep. 2014;16:372. [PMID: 24452634 DOI: 10.1007/s11894-014-0372-6] [Cited by in Crossref: 73] [Cited by in F6Publishing: 67] [Article Influence: 8.1] [Reference Citation Analysis]
|
| 147 |
Orlacchio A, Chegai F, Del Giudice C, Anselmo A, Iaria G, Palmieri G, Di Caprera E, Tosti D, Costanzo E, Tisone G, Simonetti G. Kidney transplant: usefulness of real-time elastography (RTE) in the diagnosis of graft interstitial fibrosis. Ultrasound Med Biol 2014;40:2564-72. [PMID: 25218454 DOI: 10.1016/j.ultrasmedbio.2014.06.002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 148 |
Macaluso FS, Maida M, Cammà C, Cabibbo G, Cabibi D, Alduino R, Di Marco V, Craxì A, Petta S. Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C. J Hepatol 2014;61:523-9. [PMID: 24815874 DOI: 10.1016/j.jhep.2014.04.045] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 149 |
Sebastiani G, Gkouvatsos K, Pantopoulos K. Chronic hepatitis C and liver fibrosis. World J Gastroenterol 2014; 20(32): 11033-11053 [PMID: 25170193 DOI: 10.3748/wjg.v20.i32.11033] [Cited by in CrossRef: 147] [Cited by in F6Publishing: 152] [Article Influence: 16.3] [Reference Citation Analysis]
|
| 150 |
Frulio N, Trillaud H, Perez P, Asselineau J, Vandenhende M, Hessamfar M, Bonnet F, Maire F, Delaune J, De Ledinghen V, Morlat P. Acoustic Radiation Force Impulse (ARFI) and Transient Elastography (TE) for evaluation of liver fibrosis in HIV-HCV co-infected patients. BMC Infect Dis. 2014;14:405. [PMID: 25041708 DOI: 10.1186/1471-2334-14-405] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 151 |
Leroy V, Sturm N, Faure P, Trocme C, Marlu A, Hilleret MN, Morel F, Zarski JP. Prospective evaluation of FibroTest®, FibroMeter®, and HepaScore® for staging liver fibrosis in chronic hepatitis B: comparison with hepatitis C. J Hepatol 2014;61:28-34. [PMID: 24631902 DOI: 10.1016/j.jhep.2014.02.029] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 152 |
Hu XR, Cui XN, Hu QT, Chen J. Value of MR diffusion imaging in hepatic fibrosis and its correlations with serum indices. World J Gastroenterol 2014; 20(24): 7964-7970 [PMID: 24976733 DOI: 10.3748/wjg.v20.i24.7964] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 153 |
Expert Panel on Liver Stiffness Measurement. Clinical Application of Transient Elastography in the Diagnosis of Liver Fibrosis: an Expert Panel Review and Opinion. J Clin Transl Hepatol 2014;2:110-6. [PMID: 26357622 DOI: 10.14218/JCTH.2014.00008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 154 |
Suk KT, Kim DY, Sohn KM, Kim DJ. Biomarkers of liver fibrosis. Adv Clin Chem 2013;62:33-122. [PMID: 24772665 DOI: 10.1016/b978-0-12-800096-0.00002-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 155 |
Petersen JR, Stevenson HL, Kasturi KS, Naniwadekar A, Parkes J, Cross R, Rosenberg WM, Xiao SY, Snyder N. Evaluation of the aspartate aminotransferase/platelet ratio index and enhanced liver fibrosis tests to detect significant fibrosis due to chronic hepatitis C. J Clin Gastroenterol 2014;48:370-6. [PMID: 24045284 DOI: 10.1097/MCG.0b013e3182a87e78] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 156 |
Kayadibi H, Yasar B, Ozkara S, Serdar MA, Kurdas OO, Gonen C. The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis. Scand J Clin Lab Invest 2014;74:240-7. [PMID: 24460024 DOI: 10.3109/00365513.2013.879392] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 157 |
Barr DC, Hussain HK. Magnetic Resonance Imaging in Cirrhosis: What’s New? Topics in Magnetic Resonance Imaging 2014;23:129-49. [DOI: 10.1097/rmr.0000000000000017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 158 |
Hanouneh IA, Zein NN, Cikach F, Dababneh L, Grove D, Alkhouri N, Lopez R, Dweik RA. The breathprints in patients with liver disease identify novel breath biomarkers in alcoholic hepatitis. Clin Gastroenterol Hepatol 2014;12:516-23. [PMID: 24036050 DOI: 10.1016/j.cgh.2013.08.048] [Cited by in Crossref: 77] [Cited by in F6Publishing: 80] [Article Influence: 8.6] [Reference Citation Analysis]
|
| 159 |
Hanouneh IA, Zein NN, Cikach F, Dababneh L, Grove D, Alkhouri N, Lopez R, Dweik RA. The breathprints in patients with liver disease identify novel breath biomarkers in alcoholic hepatitis. Clin Gastroenterol Hepatol 2014;12:516-23. [PMID: 24036050 DOI: 10.1016/j.cgh.2013.08.048] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 160 |
Allan RB, Thoirs KA. A comparison of liver surface and hepatic vein wall ultrasound as markers for fibrosis or cirrhosis of the liver. Radiography 2014;20:8-14. [DOI: 10.1016/j.radi.2013.09.001] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 161 |
Alboraie M, Khairy M, Elsharkawy A, Elsharkawy M, Asem N, Abo El-Seoud AR, Elghamry FG, Esmat G. Egy-score as a noninvasive score for the assessment of hepatic fibrosis in chronic hepatitis C: a preliminary approach. Saudi J Gastroenterol 2014;20:170-4. [PMID: 24976280 DOI: 10.4103/1319-3767.133003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 162 |
Sul AR. Serum liver fibrosis test. J Korean Med Assoc 2014;57:704. [DOI: 10.5124/jkma.2014.57.8.704] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 163 |
Wang CZ, Zheng J, Huang ZP, Xiao Y, Song D, Zeng J, Zheng HR, Zheng RQ. Influence of measurement depth on the stiffness assessment of healthy liver with real-time shear wave elastography. Ultrasound Med Biol 2014;40:461-9. [PMID: 24361224 DOI: 10.1016/j.ultrasmedbio.2013.10.021] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 164 |
Klironomos S, Notas G, Sfakianaki O, Kiagiadaki F, Xidakis C, Kouroumalis E. Octreotide modulates the effects on fibrosis of TNF-α, TGF-β and PDGF in activated rat hepatic stellate cells. Regul Pept. 2014;188:5-12. [PMID: 24291170 DOI: 10.1016/j.regpep.2013.11.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 165 |
Ketkar-Atre A, Struys T, Dresselaers T, Hodenius M, Mannaerts I, Ni Y, Lambrichts I, Van Grunsven LA, De Cuyper M, Himmelreich U. In vivo hepatocyte MR imaging using lactose functionalized magnetoliposomes. Biomaterials 2014;35:1015-24. [PMID: 24210051 DOI: 10.1016/j.biomaterials.2013.10.029] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 166 |
Fuchs BC, Wang H, Yang Y, Wei L, Polasek M, Schühle DT, Lauwers GY, Parkar A, Sinskey AJ, Tanabe KK, Caravan P. Molecular MRI of collagen to diagnose and stage liver fibrosis. J Hepatol 2013;59:992-8. [PMID: 23838178 DOI: 10.1016/j.jhep.2013.06.026] [Cited by in Crossref: 112] [Cited by in F6Publishing: 115] [Article Influence: 11.2] [Reference Citation Analysis]
|
| 167 |
Suzuki D, Yu K, Ohnishi K. A quantitative stiffness assessment method in liver biopsy teleoperations. IECON 2013 - 39th Annual Conference of the IEEE Industrial Electronics Society 2013. [DOI: 10.1109/iecon.2013.6699654] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 168 |
Cui XW, Friedrich-Rust M, Molo CD, Ignee A, Schreiber-Dietrich D, Dietrich CF. Liver elastography, comments on EFSUMB elastography guidelines 2013. World J Gastroenterol 2013; 19(38): 6329-6347 [PMID: 24151351 DOI: 10.3748/wjg.v19.i38.6329] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 169 |
Pellicoro A, Iredale JP. Reply to Elastin-based molecular MRI of liver fibrosis. Hepatology 2013;58:1518-9. [PMID: 23424101 DOI: 10.1002/hep.26332] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 170 |
Chen D, Luo X, Xie H, Gao Z, Fang H, Huang J. Characteristics of IL-17 induction by Schistosoma japonicum infection in C57BL/6 mouse liver. Immunology. 2013;139:523-532. [PMID: 23551262 DOI: 10.1111/imm.12105] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 171 |
El-Kamary SS, Mohamed MM, El-Raziky M, Shardell MD, Shaker OG, ElAkel WA, Esmat G. Liver fibrosis staging through a stepwise analysis of non-invasive markers (FibroSteps) in patients with chronic hepatitis C infection. Liver Int 2013;33:982-90. [PMID: 23509874 DOI: 10.1111/liv.12139] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 172 |
Wang C, Xiao Y, Song D, Ming Y, Zheng H, Zheng J, Zeng J, Huang Z, Zheng R. How the measurement depth influences the liver stiffness assessment using real-time shear wave elastography (SWE). 2013 IEEE International Ultrasonics Symposium (IUS) 2013. [DOI: 10.1109/ultsym.2013.0004] [Reference Citation Analysis]
|
| 173 |
Kim AY. Management algorithm for genotype 1 hepatitis C virus. F1000Prime Rep 2013;5:24. [PMID: 23864931 DOI: 10.12703/P5-24] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 174 |
Hernández-Bartolomé A, López-Rodríguez R, Rodríguez-Muñoz Y, Martín-Vílchez S, Borque MJ, García-Buey L, González-Moreno L, Real Y, Moreno-Otero R, Sanz-Cameno P. Angiopoietin-2 Serum Levels Improve Noninvasive Fibrosis Staging in Chronic Hepatitis C: A Fibrogenic-Angiogenic Link. PLoS One 2013;8:e66143. [PMID: 23823085 DOI: 10.1371/journal.pone.0066143] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 175 |
Alboraie MA, Afifi ME, Elghamry FG, Shalaby HA, Elshennawy GE, Abdelaziz AA, Shaheen MU, Abo El-Seoud AR. Egy-score predicts severe hepatic fibrosis and cirrhosis in Egyptians with chronic liver diseases: a pilot study. Hepat Mon 2013;13:e10810. [PMID: 24046790 DOI: 10.5812/hepatmon.10810] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 176 |
Chow AM, Tan M, Gao DS, Fan SJ, Cheung JS, Man K, Lu ZR, Wu EX. Molecular MRI of liver fibrosis by a peptide-targeted contrast agent in an experimental mouse model. Invest Radiol 2013;48:46-54. [PMID: 23192162 DOI: 10.1097/RLI.0b013e3182749c0b] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 177 |
Chen YP, Peng J, Hou JL. Non-invasive assessment of liver fibrosis in patients with chronic hepatitis B. Hepatol Int 2013;7:356-68. [PMID: 26201770 DOI: 10.1007/s12072-013-9439-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 178 |
Calvaruso V, Di Marco V, Ferraro D, Petta S, Calì A, Grazia Bavetta M, Conte E, Luigi Almasio P. Fibrosis evaluation by transient elastography in patients with long-term sustained HCV clearance. Hepat Mon 2013;13:e7176. [PMID: 23967020 DOI: 10.5812/hepatmon.7176] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 179 |
Schuppan D, Kim YO. Evolving therapies for liver fibrosis. J Clin Invest. 2013;123:1887-1901. [PMID: 23635787 DOI: 10.1172/jci66028] [Cited by in Crossref: 435] [Cited by in F6Publishing: 461] [Article Influence: 43.5] [Reference Citation Analysis]
|
| 180 |
Ue M, Ikebe N, Munekage K, Ochi T, Hirose A, Kataoka H, Fujimoto S, Kikuchi K, Okuhara Y, Ono M, Saibara T. Hepatocyte destruction with enhanced collagen synthesis: characteristic feature of chronic hepatitis C patients on haemodialysis. J Viral Hepat 2013;20:350-7. [PMID: 23565618 DOI: 10.1111/jvh.12031] [Reference Citation Analysis]
|
| 181 |
Villar Balboa I, Carrillo Muñoz R, Regí Bosque M. Métodos no invasivos en la evaluación de la fibrosis hepática: elastografía de transición. FMC - Formación Médica Continuada en Atención Primaria 2013;20:213-216. [DOI: 10.1016/s1134-2072(13)70558-9] [Reference Citation Analysis]
|
| 182 |
Potthoff A, Attia D, Pischke S, Kirschner J, Mederacke I, Wedemeyer H, Manns MP, Gebel MJ, Rifai K. Influence of different frequencies and insertion depths on the diagnostic accuracy of liver elastography by acoustic radiation force impulse imaging (ARFI). Eur J Radiol 2013;82:1207-12. [PMID: 23523513 DOI: 10.1016/j.ejrad.2013.02.011] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 183 |
Attallah AM, El-Far M, Omran MM, Farid K, Albannan MS, El-Dosoky I. Noninvasive diagnosis of liver fibrosis and cirrhosis in chronic hepatitis C patients. J Clin Lab Anal 2013;27:121-9. [PMID: 23460258 DOI: 10.1002/jcla.21572] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 184 |
Guha IN, Bokhandi S, Ahmad Z, Sheron N, Cope R, Marshall C, Veldtman G. Structural and functional uncoupling of liver performance in the Fontan circulation. International Journal of Cardiology 2013;164:77-81. [DOI: 10.1016/j.ijcard.2011.06.062] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 185 |
Wu YM, Xu N, Hu JY, Xu XF, Wu WX, Gao SX, Zhu WJ, Wu WL, Shen XZ, Wang JY, Wu SD. A simple noninvasive index to predict significant liver fibrosis in patients with advanced schistosomiasis japonica. Parasitol Int 2013;62:283-8. [PMID: 23466574 DOI: 10.1016/j.parint.2013.02.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 186 |
Yu S, Kim S, Paek M, Goo E, Ji Y, Choe B. Correlation between Hepatic Fat Content Using 3-Echo 3-D Dixon Method and Intravoxel Incoherent Motion (IVIM) Perfusion MR Imaging. Appl Magn Reson 2013;44:791-801. [DOI: 10.1007/s00723-013-0443-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 187 |
Poynard T, Bruix J, Schiff ER, Diago M, Berg T, Moreno-Otero R, Lyra AC, Carrilho F, Griffel LH, Boparai N, Jiang R, Burroughs M, Brass CA, Albrecht JK. Improved inflammatory activity with peginterferon alfa-2b maintenance therapy in non-cirrhotic prior non-responders: a randomized study. J Hepatol 2013;58:452-9. [PMID: 23159770 DOI: 10.1016/j.jhep.2012.11.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 188 |
Yang HR. Noninvasive diagnosis of pediatric nonalcoholic fatty liver disease. Korean J Pediatr 2013;56:45-51. [PMID: 23482433 DOI: 10.3345/kjp.2013.56.2.45] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 189 |
Fujimoto K, Kato M, Kudo M, Yada N, Shiina T, Ueshima K, Yamada Y, Ishida T, Azuma M, Yamasaki M. Novel image analysis method using ultrasound elastography for noninvasive evaluation of hepatic fibrosis in patients with chronic hepatitis C. Oncology. 2013;84 Suppl 1:3-12. [PMID: 23428852 DOI: 10.1159/000345883] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 190 |
Marcellin P, Gane E, Buti M, Afdhal N, Sievert W, Jacobson IM, Washington MK, Germanidis G, Flaherty JF, Aguilar Schall R, Bornstein JD, Kitrinos KM, Subramanian GM, McHutchison JG, Heathcote EJ. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet 2013;381:468-75. [PMID: 23234725 DOI: 10.1016/S0140-6736(12)61425-1] [Cited by in Crossref: 1219] [Cited by in F6Publishing: 1226] [Article Influence: 121.9] [Reference Citation Analysis]
|
| 191 |
Valva P, Casciato P, Lezama C, Galoppo M, Gadano A, Galdame O, Galoppo MC, Mullen E, De Matteo E, Preciado MV. Serum apoptosis markers related to liver damage in chronic hepatitis C: sFas as a marker of advanced fibrosis in children and adults while M30 of severe steatosis only in children. PLoS One. 2013;8:e53519. [PMID: 23326448 DOI: 10.1371/journal.pone.0053519] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 192 |
Chen J, Liu C, Chen H, Liu Q, Yang B, Ou Q. Study on noninvasive laboratory tests for fibrosis in chronic HBV infection and their evaluation. J Clin Lab Anal. 2013;27:5-11. [PMID: 23292737 DOI: 10.1002/jcla.21554] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 193 |
Gressner AM, Arndt T. E. Lexikon der Medizinischen Laboratoriumsdiagnostik 2013. [DOI: 10.1007/978-3-642-12921-6_5] [Reference Citation Analysis]
|
| 194 |
Che XH, Jiang WY, Parajuli DR, Zhao YZ, Lee SH, Sohn DH. Apoptotic effect of propyl gallate in activated rat hepatic stellate cells. Arch Pharm Res 2012;35:2205-10. [PMID: 23263816 DOI: 10.1007/s12272-012-1219-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 195 |
Li F, Zhu CL, Zhang H, Huang H, Wei Q, Zhu X, Cheng XY. Role of hyaluronic acid and laminin as serum markers for predicting significant fibrosis in patients with chronic hepatitis B. Braz J Infect Dis 2012;16:9-14. [PMID: 22358349 DOI: 10.1016/s1413-8670(12)70267-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 26] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 196 |
Polasek M, Fuchs BC, Uppal R, Schühle DT, Alford JK, Loving GS, Yamada S, Wei L, Lauwers GY, Guimaraes AR, Tanabe KK, Caravan P. Molecular MR imaging of liver fibrosis: a feasibility study using rat and mouse models. J Hepatol 2012;57:549-55. [PMID: 22634342 DOI: 10.1016/j.jhep.2012.04.035] [Cited by in Crossref: 81] [Cited by in F6Publishing: 86] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 197 |
Zhu J, Fan JR, Pan L, Huang H, Xiao MB, Jiang F, Lu CH. Correlation of nuclear factor κB expression with α-SMA and collagen Ⅲ expression in hepatic fibrosis in rats. Shijie Huaren Xiaohua Zazhi 2012; 20(22): 2081-2085 [DOI: 10.11569/wcjd.v20.i22.2081] [Reference Citation Analysis]
|
| 198 |
Chládek J, S̆imková M, Vanec̆ková J, Hroch M, Vávrová J, Hůlek P. Assessment of methotrexate hepatotoxicity in psoriasis patients: a prospective evaluation of four serum fibrosis markers: Markers of live fibrosis in psoriasis. Journal of the European Academy of Dermatology and Venereology 2013;27:1007-14. [DOI: 10.1111/j.1468-3083.2012.04643.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 199 |
Bacchetti P, Boylan R. Estimating complex multi-state misclassification rates for biopsy-measured liver fibrosis in patients with hepatitis C. Int J Biostat 2009;5:Article 5. [PMID: 20104258 DOI: 10.2202/1557-4679.1139] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 200 |
Liu T, Wang X, Karsdal MA, Leeming DJ, Genovese F. Molecular serum markers of liver fibrosis. Biomark Insights. 2012;7:105-117. [PMID: 22872786 DOI: 10.4137/bmi.s10009] [Cited by in Crossref: 84] [Cited by in F6Publishing: 103] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 201 |
Ikeda H, Yatomi Y. Autotaxin in liver fibrosis. Clin Chim Acta. 2012;413:1817-1821. [PMID: 22820036 DOI: 10.1016/j.cca.2012.07.014] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 202 |
El-Shabrawi MH, Zein El Abedin MY, Omar N, Kamal NM, Elmakarem SA, Khattab S, El-Sayed HM, El-Hennawy A, Ali AS. Predictive accuracy of serum hyaluronic acid as a non-invasive marker of fibrosis in a cohort of multi-transfused Egyptian children with β-thalassaemia major. Arab J Gastroenterol. 2012;13:45-48. [PMID: 22980590 DOI: 10.1016/j.ajg.2012.06.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 203 |
Chen YP, Liang XE, Zhang Q, Peng J, Zhu YF, Wen WQ, Hou JL. Larger biopsies evaluation of transient elastography for detecting advanced fibrosis in patients with compensated chronic hepatitis B. J Gastroenterol Hepatol 2012;27:1219-26. [PMID: 22414330 DOI: 10.1111/j.1440-1746.2012.07122.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 204 |
Attallah AM, Omran MM, Farid K, El-Bendary M, Emran TM, Albannan MS, El-Dosoky I. Development of a novel score for liver fibrosis staging and comparison with eight simple laboratory scores in large numbers of HCV-monoinfected patients. Clin Chim Acta. 2012;413:1725-1730. [PMID: 22759976 DOI: 10.1016/j.cca.2012.06.031] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 205 |
Frenzel C, Koch J, Lorenzen V, Werner T, Lohse AW, Denzer UW. Complications and risk factors in 2731 diagnostic mini-laparoscopies in patients with liver disease. Liver Int 2012;32:970-6. [PMID: 22405026 DOI: 10.1111/j.1478-3231.2012.02767.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 206 |
Luo WS, Jin YL, Ou SY, Qin H, Sun XR. Effect of total flavone of Litchi chinensis Sonn on the expression of Bcl-2 and Bax in hepatic fibrosis in rats. Shijie Huaren Xiaohua Zazhi 2012; 20(18): 1602-1608 [DOI: 10.11569/wcjd.v20.i18.1602] [Reference Citation Analysis]
|
| 207 |
Hall A, Germani G, Isgrò G, Burroughs AK, Dhillon AP. Fibrosis distribution in explanted cirrhotic livers. Histopathology. 2012;60:270-277. [PMID: 22211285 DOI: 10.1111/j.1365-2559.2011.04094.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 208 |
Vassilopoulos D, Calabrese LH. Management of rheumatic disease with comorbid HBV or HCV infection. Nat Rev Rheumatol 2012;8:348-57. [DOI: 10.1038/nrrheum.2012.63] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 209 |
Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 2012;142:1293-1302.e4. [PMID: 22537436 DOI: 10.1053/j.gastro.2012.02.017] [Cited by in Crossref: 438] [Cited by in F6Publishing: 461] [Article Influence: 39.8] [Reference Citation Analysis]
|
| 210 |
Loguercio C, Andreone P, Brisc C, Brisc MC, Bugianesi E, Chiaramonte M, Cursaro C, Danila M, de Sio I, Floreani A, Freni MA, Grieco A, Groppo M, Lazzari R, Lobello S, Lorefice E, Margotti M, Miele L, Milani S, Okolicsanyi L, Palasciano G, Portincasa P, Saltarelli P, Smedile A, Somalvico F, Spadaro A, Sporea I, Sorrentino P, Vecchione R, Tuccillo C, Del Vecchio Blanco C, Federico A. Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Free Radic Biol Med 2012;52:1658-65. [PMID: 22343419 DOI: 10.1016/j.freeradbiomed.2012.02.008] [Cited by in Crossref: 161] [Cited by in F6Publishing: 165] [Article Influence: 14.6] [Reference Citation Analysis]
|
| 211 |
Patouraux S, Bonnafous S, Voican CS, Anty R, Saint-Paul MC, Rosenthal-Allieri MA, Agostini H, Njike M, Barri-Ova N, Naveau S, Le Marchand-Brustel Y, Veillon P, Calès P, Perlemuter G, Tran A, Gual P. The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver disease. PLoS One 2012;7:e35612. [PMID: 22530059 DOI: 10.1371/journal.pone.0035612] [Cited by in Crossref: 64] [Cited by in F6Publishing: 68] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 212 |
Cardoso AC, Carvalho-Filho RJ, Stern C, Dipumpo A, Giuily N, Ripault MP, Asselah T, Boyer N, Lada O, Castelnau C, Martinot-Peignoux M, Valla DC, Bedossa P, Marcellin P. Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C. Liver Int 2012;32:612-21. [PMID: 22103765 DOI: 10.1111/j.1478-3231.2011.02660.x] [Cited by in Crossref: 105] [Cited by in F6Publishing: 113] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 213 |
Berres ML, Schlosser B, Berg T, Trautwein C, Wasmuth HE. Soluble urokinase plasminogen activator receptor is associated with progressive liver fibrosis in hepatitis C infection. J Clin Gastroenterol 2012;46:334-8. [PMID: 21934527 DOI: 10.1097/MCG.0b013e31822da19d] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 214 |
Poynard T, Lassailly G, Diaz E, Clement K, Caïazzo R, Tordjman J, Munteanu M, Perazzo H, Demol B, Callafe R. Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data. PLoS One. 2012;7:e30325. [PMID: 22431959 DOI: 10.1371/journal.pone.0030325] [Cited by in Crossref: 95] [Cited by in F6Publishing: 99] [Article Influence: 8.6] [Reference Citation Analysis]
|
| 215 |
Sethi S, Simonetto DA, Abdelmoneim SS, Campion MB, Kaloiani I, Clayton AC, Kremers WK, Halling KC, Kamath PS, Talwalkar J, Shah VH. Comparison of circulating endothelial cell/platelet count ratio to aspartate transaminase/platelet ratio index for identifying patients with cirrhosis. J Clin Exp Hepatol 2012;2:19-26. [PMID: 25755402 DOI: 10.1016/S0973-6883(12)60078-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 216 |
Orlacchio A, Bolacchi F, Antonicoli M, Coco I, Costanzo E, Tosti D, Francioso S, Angelico M, Simonetti G. Liver elasticity in NASH patients evaluated with real-time elastography (RTE). Ultrasound Med Biol. 2012;38:537-544. [PMID: 22341049 DOI: 10.1016/j.ultrasmedbio.2011.12.023] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 217 |
Chow AM, Gao DS, Fan SJ, Qiao Z, Lee FY, Yang J, Man K, Wu EX. Liver fibrosis: An intravoxel incoherent motion (IVIM) study. J Magn Reson Imaging 2012;36:159-67. [DOI: 10.1002/jmri.23607] [Cited by in Crossref: 85] [Cited by in F6Publishing: 88] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 218 |
Chow AM, Gao DS, Fan SJ, Qiao Z, Lee FY, Yang J, Man K, Wu EX. Measurement of liver T1 and T2 relaxation times in an experimental mouse model of liver fibrosis. J Magn Reson Imaging 2012;36:152-8. [DOI: 10.1002/jmri.23606] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 219 |
Miki D, Ohishi W, Ochi H, Hayes CN, Abe H, Tsuge M, Imamura M, Kamatani N, Nakamura Y, Chayama K. Serum PAI-1 is a novel predictor for response to pegylated interferon-α-2b plus ribavirin therapy in chronic hepatitis C virus infection. J Viral Hepat 2012;19:e126-33. [PMID: 22239510 DOI: 10.1111/j.1365-2893.2011.01516.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 220 |
Luan Y, Ju J, Luo L, Zhang Z, Wang J, Zhu DM, Cheng L, Zhang SY, Chen L, Wang FS, Wang S. Potential role of soluble B7-H3 in liver immunopathogenesis during chronic HBV infection. J Viral Hepat 2012;19:23-31. [PMID: 22187944 DOI: 10.1111/j.1365-2893.2010.01421.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 221 |
Bedossa P, Paradis V. Cellular and molecular techniques. MacSween's Pathology of the Liver 2012. [DOI: 10.1016/b978-0-7020-3398-8.00002-7] [Reference Citation Analysis]
|
| 222 |
Poynard T, Imbert-bismut F. Laboratory Testing for Liver Disease. Zakim and Boyer's Hepatology. Elsevier; 2012. pp. 201-15. [DOI: 10.1016/b978-1-4377-0881-3.00014-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 223 |
Sebastiani G, Halfon P, Castera L, Mangia A, Di Marco V, Pirisi M, Voiculescu M, Bourliere M, Alberti A. Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C. Aliment Pharmacol Ther 2012;35:92-104. [PMID: 22035045 DOI: 10.1111/j.1365-2036.2011.04897.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 224 |
Dufour DR. Liver Disease. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Elsevier; 2012. pp. 1637-93. [DOI: 10.1016/b978-1-4160-6164-9.00050-0] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 225 |
Sebastiani G, Alberti A. How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C? J Viral Hepat 2012;19 Suppl 1:18-32. [PMID: 22233410 DOI: 10.1111/j.1365-2893.2011.01518.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 226 |
Chen YP, Liang XE, Dai L, Zhang Q, Peng J, Zhu YF, Wen WQ, Chan HL, Hou JL. Improving transient elastography performance for detecting hepatitis B cirrhosis. Dig Liver Dis 2012;44:61-6. [PMID: 21907650 DOI: 10.1016/j.dld.2011.08.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 227 |
Aghemo A, Colombo M. Peginterferon maintenance therapy in patients with advanced hepatitis C to prevent hepatocellular carcinoma: the plot thickens. J Hepatol 2012;56:276-8. [PMID: 21782763 DOI: 10.1016/j.jhep.2011.05.034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 228 |
Liang XE, Chen YP, Zhang Q, Dai L, Zhu YF, Hou JL. Dynamic evaluation of liver stiffness measurement to improve diagnostic accuracy of liver cirrhosis in patients with chronic hepatitis B acute exacerbation. J Viral Hepat 2011;18:884-91. [PMID: 21062388 DOI: 10.1111/j.1365-2893.2010.01389.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 229 |
Lai M, Afdhal NH. Editorial: staging liver fibrosis in hepatitis C: a challenge for this decade. Am J Gastroenterol 2011;106:2121-2. [PMID: 22138940 DOI: 10.1038/ajg.2011.343] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 230 |
Rizzo L, Calvaruso V, Cacopardo B, Alessi N, Attanasio M, Petta S, Fatuzzo F, Montineri A, Mazzola A, L'abbate L, Nunnari G, Bronte F, Di Marco V, Craxì A, Cammà C. Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. Am J Gastroenterol 2011;106:2112-20. [PMID: 21971536 DOI: 10.1038/ajg.2011.341] [Cited by in Crossref: 142] [Cited by in F6Publishing: 144] [Article Influence: 11.8] [Reference Citation Analysis]
|
| 231 |
Ogawa E, Furusyo N, Murata M, Ohnishi H, Toyoda K, Taniai H, Ihara T, Ikezaki H, Hayashi T, Kainuma M, Hayashi J. Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis B patients treated with nucleoside analog. Hepatol Res 2011;41:1178-88. [PMID: 21917085 DOI: 10.1111/j.1872-034X.2011.00869.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 232 |
Fransen van de Putte DE, Fischer K, de Knegt RJ, Posthouwer D, van Erpecum KJ, Biesma DH, Mauser-Bunschoten EP. Beneficial effect of successful HCV treatment in patients with inherited bleeding disorders, assessed by liver stiffness measurements. Haemophilia 2012;18:e266-72. [PMID: 22103568 DOI: 10.1111/j.1365-2516.2011.02697.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 233 |
Zhang W, Yi Z, Ye CG, Liu CY, Sun SL, Li JM, Xi WN. Interferon α-2a reduces carbon tetrachloride-induced hepatic fibrosis in rats. Shijie Huaren Xiaohua Zazhi 2011; 19(31): 3207-3211 [DOI: 10.11569/wcjd.v19.i31.3207] [Reference Citation Analysis]
|
| 234 |
Sebastiani G, Castera L, Halfon P, Pol S, Mangia A, Di Marco V, Pirisi M, Voiculescu M, Bourliere M, Alberti A. The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases. Aliment Pharmacol Ther 2011;34:1202-16. [PMID: 21981787 DOI: 10.1111/j.1365-2036.2011.04861.x] [Cited by in Crossref: 96] [Cited by in F6Publishing: 80] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 235 |
Dogan S, Celikbilek M, Baldane S, Torun E, Gursoy S. Meperidine: a safe analgezic option for percutaneous liver biopsy. Eur J Gastroenterol Hepatol 2011;23:1078. [PMID: 21971340 DOI: 10.1097/MEG.0b013e32834b9588] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 236 |
Mannelli L, Godfrey E, Graves MJ, Patterson AJ, Beddy P, Bowden D, Joubert I, Priest AN, Lomas DJ. Magnetic resonance elastography: feasibility of liver stiffness measurements in healthy volunteers at 3T. Clin Radiol. 2012;67:258-262. [PMID: 22014555 DOI: 10.1016/j.crad.2011.08.022] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 237 |
Marabita F, Aghemo A, De Nicola S, Rumi MG, Cheroni C, Scavelli R, Crimi M, Soffredini R, Abrignani S, De Francesco R, Colombo M. Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection. Hepatology 2011;54:1127-34. [PMID: 21721028 DOI: 10.1002/hep.24503] [Cited by in Crossref: 102] [Cited by in F6Publishing: 107] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 238 |
Ebinuma H, Saito H, Komuta M, Ojiro K, Wakabayashi K, Usui S, Chu PS, Umeda R, Ishibashi Y, Takayama T, Kikuchi M, Nakamoto N, Yamagishi Y, Kanai T, Ohkuma K, Sakamoto M, Hibi T. Evaluation of liver fibrosis by transient elastography using acoustic radiation force impulse: comparison with Fibroscan(®). J Gastroenterol 2011;46:1238-48. [PMID: 21779759 DOI: 10.1007/s00535-011-0437-3] [Cited by in Crossref: 85] [Cited by in F6Publishing: 90] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 239 |
Guha IN, Myers RP, Patel K, Talwalkar JA. Biomarkers of liver fibrosis: what lies beneath the receiver operating characteristic curve? Hepatology 2011;54:1454-62. [PMID: 21725995 DOI: 10.1002/hep.24515] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 240 |
Nobili V, Monti L, Alisi A, Lo Zupone C, Pietrobattista A, Tomà P. Transient elastography for assessment of fibrosis in paediatric liver disease. Pediatr Radiol 2011;41:1232-8. [PMID: 21678114 DOI: 10.1007/s00247-011-2143-y] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 241 |
Scaglia E, Sockalingum GD, Schmitt J, Gobinet C, Schneider N, Manfait M, Thiéfin G. Noninvasive assessment of hepatic fibrosis in patients with chronic hepatitis C using serum Fourier transform infrared spectroscopy. Anal Bioanal Chem 2011;401:2919-25. [DOI: 10.1007/s00216-011-5402-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 242 |
Chen BB, Hsu CY, Yu CW, Wei SY, Kao JH, Lee HS, Shih TT. Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients. Eur Radiol. 2012;22:171-180. [PMID: 21879400 DOI: 10.1007/s00330-011-2249-5] [Cited by in Crossref: 81] [Cited by in F6Publishing: 83] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 243 |
Valva P, Casciato P, Diaz Carrasco JM, Gadano A, Galdame O, Galoppo MC, Mullen E, De Matteo E, Preciado MV. The role of serum biomarkers in predicting fibrosis progression in pediatric and adult hepatitis C virus chronic infection. PLoS One. 2011;6:e23218. [PMID: 21858035 DOI: 10.1371/journal.pone.0023218] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 244 |
Baranova A, Lal P, Birerdinc A, Younossi ZM. Non-invasive markers for hepatic fibrosis. BMC Gastroenterol. 2011;11:91. [PMID: 21849046 DOI: 10.1186/1471-230x-11-91] [Cited by in Crossref: 194] [Cited by in F6Publishing: 210] [Article Influence: 16.2] [Reference Citation Analysis]
|
| 245 |
Resino S, Asensio C, Bellón JM, Carmona R, Miralles P, López JC, Cosín J, Álvarez E, Berenguer J. Diagnostic accuracy of the APRI, FIB-4, and the Forns index for predicting liver fibrosis in HIV/HCV-coinfected patients: a validation study. J Infect. 2011;63:402-405. [PMID: 21839774 DOI: 10.1016/j.jinf.2011.07.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 246 |
Cheung KJ, Tilleman K, Deforce D, Colle I, Moreno C, Gustot T, Van Vlierberghe H. Usefulness of a novel serum proteome-derived index FI-PRO (fibrosis-protein) in the prediction of fibrosis in chronic hepatitis C. Eur J Gastroenterol Hepatol 2011;23:701-10. [PMID: 21623191 DOI: 10.1097/MEG.0b013e3283471b74] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 247 |
Carrión JA, Navasa M, Buti M, Torras X, Xiol X, Vergara M, Planas R, Solà R, Forns X. Elastografía hepática. Documento de posicionamiento de la Societat Catalana de Digestologia. Gastroenterología y Hepatología 2011;34:504-10. [DOI: 10.1016/j.gastrohep.2011.05.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 248 |
Ebinuma H, Saito H, Komuta M, Ojiro K, Wakabayashi K, Usui S, Chu PS, Umeda R, Ishibashi Y, Takayama T. Evaluation of liver fibrosis by transient elastography using acoustic radiation force impulse: comparison with Fibroscan(®). J Gastroenterol. 2011;46:1238-1248. [PMID: 21779759 DOI: 10.1007/s00535] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 249 |
McNear S, Harrison SA. Current status of therapy in nonalcoholic Fatty liver disease. Therap Adv Gastroenterol. 2009;2:29-43. [PMID: 21180532 DOI: 10.1177/1756283x08100327] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 250 |
Sánchez-Conde M, Montes Ramírez ML, Bellón Cano JM, Caminoa A, Alvarez Rodríguez F, González Garcia J, Miralles Martín P, Bernardino de la Serna I, Bernardo de Quirós JC, Arribas López JR, Cosín Ochaíta J, Pascual Pareja JF, Alvarez E, Berenguer JB. Impact of liver steatosis on the correlation between liver stiffness and fibrosis measured by transient elastography in patients coinfected with human immunodeficiency virus and hepatitis C virus. J Viral Hepat 2011;18:e278-83. [PMID: 21129129 DOI: 10.1111/j.1365-2893.2010.01407.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 251 |
Tacke F, Zimmermann HW, Berres ML, Trautwein C, Wasmuth HE. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases. Liver Int 2011;31:840-9. [PMID: 21645215 DOI: 10.1111/j.1478-3231.2011.02504.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 252 |
Li J, Liu P, Zhang R, Cao L, Qian H, Liao J, Xu W, Wu M, Yin Z. Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats. J Ethnopharmacol. 2011;137:714-723. [PMID: 21726622 DOI: 10.1016/j.jep.2011.06.030] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 253 |
Bacchetti P, Boylan R, Astemborski J, Shen H, Mehta SH, Thomas DL, Terrault NA, Monto A. Progression of biopsy-measured liver fibrosis in untreated patients with hepatitis C infection: non-Markov multistate model analysis. PLoS One 2011;6:e20104. [PMID: 21637766 DOI: 10.1371/journal.pone.0020104] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 254 |
Omran MM, Farid K, Emran TM, Attallah AA. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients. Arab J Gastroenterol. 2011;12:74-79. [PMID: 21684477 DOI: 10.1016/j.ajg.2011.04.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 255 |
Clark PJ, Patel K. Noninvasive tools to assess liver disease. Curr Opin Gastroenterol 2011;27:210-6. [PMID: 21248634 DOI: 10.1097/MOG.0b013e328343e9a3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 256 |
Fransen van de Putte DE, Fischer K, de Knegt RJ, Posthouwer D, van Erpecum KJ, Mauser-Bunschoten EP. Liver stiffness measurements to assess progression of fibrosis in HCV-infected patients with inherited bleeding disorders. Haemophilia 2011;17:e975-80. [PMID: 21535322 DOI: 10.1111/j.1365-2516.2011.02542.x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 257 |
Poynard T, Munteanu M, Deckmyn O, Ngo Y, Drane F, Messous D, Castille JM, Housset C, Ratziu V, Imbert-Bismut F. Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age. BMC Gastroenterol 2011;11:39. [PMID: 21492460 DOI: 10.1186/1471-230X-11-39] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 258 |
Lavallard VJ, Bonnafous S, Patouraux S, Saint-Paul MC, Rousseau D, Anty R, Le Marchand-Brustel Y, Tran A, Gual P. Serum markers of hepatocyte death and apoptosis are non invasive biomarkers of severe fibrosis in patients with alcoholic liver disease. PLoS One. 2011;6:e17599. [PMID: 21445263 DOI: 10.1371/journal.pone.0017599] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 259 |
Nakagawa H, Ikeda H, Nakamura K, Ohkawa R, Masuzaki R, Tateishi R, Yoshida H, Watanabe N, Tejima K, Kume Y, Iwai T, Suzuki A, Tomiya T, Inoue Y, Nishikawa T, Ohtomo N, Tanoue Y, Omata M, Igarashi K, Aoki J, Koike K, Yatomi Y. Autotaxin as a novel serum marker of liver fibrosis. Clin Chim Acta. 2011;412:1201-1206. [PMID: 21419756 DOI: 10.1016/j.cca.2011.03.014] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 260 |
He Y, Kang CH, Xu S, Tuo X, Trasti S, Tai DC, Raja AM, Peng Q, So PT, Rajapakse JC, Welsch R, Yu H. Toward surface quantification of liver fibrosis progression. J Biomed Opt 2010;15:056007. [PMID: 21054101 DOI: 10.1117/1.3490414] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 261 |
Fujimoto K, Tonan T, Azuma S, Kage M, Nakashima O, Johkoh T, Hayabuchi N, Okuda K, Kawaguchi T, Sata M, Qayyum A. Evaluation of the Mean and Entropy of Apparent Diffusion Coefficient Values in Chronic Hepatitis C: Correlation with Pathologic Fibrosis Stage and Inflammatory Activity Grade. Radiology 2011;258:739-48. [DOI: 10.1148/radiol.10100853] [Cited by in Crossref: 88] [Cited by in F6Publishing: 93] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 262 |
Morikawa H, Fukuda K, Kobayashi S, Fujii H, Iwai S, Enomoto M, Tamori A, Sakaguchi H, Kawada N. Real-time tissue elastography as a tool for the noninvasive assessment of liver stiffness in patients with chronic hepatitis C. J Gastroenterol 2011;46:350-8. [PMID: 20697747 DOI: 10.1007/s00535-010-0301-x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 75] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 263 |
Cheung JS, Fan SJ, Gao DS, Chow AM, Yang J, Man K, Wu EX. In vivo lipid profiling using proton magnetic resonance spectroscopy in an experimental liver fibrosis model. Acad Radiol 2011;18:377-83. [PMID: 21167757 DOI: 10.1016/j.acra.2010.10.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 264 |
Lettow I, Berres M, Schmitz P, Müller T, Berg T, Neumann UP, Trautwein C, Wasmuth HE. A Duffy antigen receptor for chemokines (DARC) polymorphism that determines pro-fibrotic chemokine serum concentrations is not directly associated with severity of hepatitis C infection. Human Immunology 2011;72:273-7. [DOI: 10.1016/j.humimm.2010.12.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 265 |
Macías J, Mira J, Gilabert I, Neukam K, Roldán C, Viloria M, Moro A, Pineda JA. Combined use of aspartate aminotransferase, platelet count and matrix metalloproteinase 2 measurements to predict liver fibrosis in HIV/hepatitis C virus-coinfected patients. HIV Med 2011;12:14-21. [PMID: 20497249 DOI: 10.1111/j.1468-1293.2010.00836.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 266 |
Cheung JS, Fan SJ, Gao DS, Chow AM, Man K, Wu EX. Diffusion tensor imaging of liver fibrosis in an experimental model. J Magn Reson Imaging. 2010;32:1141-1148. [PMID: 21031520 DOI: 10.1002/jmri.22367] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 267 |
Poynard T, Munteanu M, Colombo M, Bruix J, Schiff E, Terg R, Flamm S, Moreno-Otero R, Carrilho F, Schmidt W, Berg T, McGarrity T, Heathcote EJ, Gonçales F, Diago M, Craxi A, Silva M, Boparai N, Griffel L, Burroughs M, Brass C, Albrecht J. FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC³ program. J Hepatol 2011;54:227-35. [PMID: 21056496 DOI: 10.1016/j.jhep.2010.06.038] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 268 |
Castera L. Non-invasive assessment of liver fibrosis in chronic hepatitis C. Hepatol Int. 2011;5:625-634. [PMID: 21484142 DOI: 10.1007/s12072-010-9240-0] [Cited by in Crossref: 57] [Cited by in F6Publishing: 64] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 269 |
Castera L, Bedossa P. How to assess liver fibrosis in chronic hepatitis C: serum markers or transient elastography vs. liver biopsy? Liver Int 2011;31 Suppl 1:13-7. [PMID: 21205132 DOI: 10.1111/j.1478-3231.2010.02380.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 53] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 270 |
Basturk O, Farris AB, Adsay NV. Immunohistology of the Pancreas, Biliary Tract, and Liver. Diagnostic Immunohistochemistry 2011. [DOI: 10.1016/b978-1-4160-5766-6.00019-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 271 |
Liu DG, Wang Y. Advances in understanding the role of the UII/UT system in the pathogenesis of portal hypertension. Shijie Huaren Xiaohua Zazhi 2010; 18(31): 3332-3337 [DOI: 10.11569/wcjd.v18.i31.3332] [Reference Citation Analysis]
|
| 272 |
Wang J, Zhao W, Cheng L, Guo M, Li D, Li X, Tan Y, Ma S, Li S, Yang Y, Chen L, Wang S. CD137-mediated pathogenesis from chronic hepatitis to hepatocellular carcinoma in hepatitis B virus-transgenic mice. J Immunol 2010;185:7654-62. [PMID: 21059892 DOI: 10.4049/jimmunol.1000927] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 273 |
Vali B, Jones RB, Sakhdari A, Sheth PM, Clayton K, Yue FY, Gyenes G, Wong D, Klein MB, Saeed S. HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression. Eur J Immunol. 2010;40:2493-2505. [PMID: 20623550 DOI: 10.1002/eji.201040340] [Cited by in Crossref: 72] [Cited by in F6Publishing: 79] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 274 |
Peters L, Rockstroh JK. Biomarkers of fibrosis and impaired liver function in chronic hepatitis C: how well do they predict clinical outcomes?: . Current Opinion in HIV and AIDS 2010;5:517-23. [DOI: 10.1097/coh.0b013e32833e3ee6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 275 |
Cheung KJ, Libbrecht L, Tilleman K, Deforce D, Colle I, Van Vlierberghe H. Galectin-3-binding protein: a serological and histological assessment in accordance with hepatitis C-related liver fibrosis. Eur J Gastroenterol Hepatol 2010;22:1066-73. [PMID: 20186066 DOI: 10.1097/MEG.0b013e328337d602] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 276 |
Resino S, Bellón JM, Asensio C, Micheloud D, Miralles P, Vargas A, Catalán P, López JC, Alvarez E, Cosin J. Can serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV/Hepatitis C coinfected patients? BMC Infect Dis. 2010;10:244. [PMID: 20723207 DOI: 10.1186/1471-2334-10-244] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 277 |
Allan R, Thoirs K, Phillips M. Accuracy of ultrasound to identify chronic liver disease. World J Gastroenterol 2010; 16(28): 3510-3520 [PMID: 20653059 DOI: 10.3748/wjg.v16.i28.3510] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 49] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 278 |
Pérez Roldán F, Vives Domínguez L, González Carro P, Villafáñez García MC, Fernández Acenero MJ, Cuesta Domínguez R, Aoufi Rabih S, Ruíz Carrillo F. [Reversibility of hepatitis B virus-induced liver cirrhosis after prolonged antiviral therapy]. Gastroenterol Hepatol 2010;33:498-503. [PMID: 20630622 DOI: 10.1016/j.gastrohep.2010.04.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 279 |
Berenguer J. [Hepatitis C virus infection in HIV coinfected patients]. Rev Clin Esp 2010;210:338-41. [PMID: 20609839 DOI: 10.1016/j.rce.2010.04.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 280 |
Park SH, Kim DJ, Cheong JY, Cho SW, Hwang SG, Lee YJ, Cho M, Yang JM, Kim YB. Noninvasive markers to diagnose cirrhosis in patients with HBeAg positive chronic hepatitis: Do new biomarkers improve the accuracy? Clinical Biochemistry 2010;43:877-81. [DOI: 10.1016/j.clinbiochem.2010.04.063] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 281 |
Hines CD, Bley TA, Lindstrom MJ, Reeder SB. Repeatability of magnetic resonance elastography for quantification of hepatic stiffness. J Magn Reson Imaging. 2010;31:725-731. [PMID: 20187219 DOI: 10.1002/jmri.22066] [Cited by in Crossref: 118] [Cited by in F6Publishing: 125] [Article Influence: 9.1] [Reference Citation Analysis]
|
| 282 |
Nunes D, Fleming C, Offner G, Craven D, Fix O, Heeren T, Koziel MJ, Graham C, Tumilty S, Skolnik P, Stuver S, Horsburgh CR Jr, Cotton D. Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection. Am J Gastroenterol 2010;105:1346-53. [PMID: 20179698 DOI: 10.1038/ajg.2009.746] [Cited by in Crossref: 121] [Cited by in F6Publishing: 117] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 283 |
Haafiz AB. Liver fibrosis in biliary atresia. Expert Rev Gastroenterol Hepatol 2010;4:335-43. [PMID: 20528120 DOI: 10.1586/egh.10.29] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 284 |
Patel K. Noninvasive tools to assess liver disease. Curr Opin Gastroenterol 2010;26:227-33. [PMID: 20179592 DOI: 10.1097/MOG.0b013e3283383c68] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 285 |
Poynard T, Lebray P, Ingiliz P, Varaut A, Varsat B, Ngo Y, Norha P, Munteanu M, Drane F, Messous D. Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest). BMC Gastroenterol. 2010;10:40. [PMID: 20412588 DOI: 10.1186/1471-230x-10-40] [Cited by in Crossref: 141] [Cited by in F6Publishing: 148] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 286 |
Sánchez-Conde M, Montes-Ramírez ML, Miralles P, Alvarez JM, Bellón JM, Ramírez M, Arribas JR, Gutiérrez I, López JC, Cosín J, Alvarez E, González J, Berenguer J. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers. J Viral Hepat 2010;17:280-6. [PMID: 19732322 DOI: 10.1111/j.1365-2893.2009.01180.x] [Cited by in Crossref: 82] [Cited by in F6Publishing: 74] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 287 |
Bedossa P. Harmony in liver fibrosis.. J Hepatol 2010;52:313-4. [PMID: 20133004 DOI: 10.1016/j.jhep.2009.11.020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 288 |
Bacchetti P, Boylan RD, Terrault NA, Monto A, Berenguer M. Non-Markov multistate modeling using time-varying covariates, with application to progression of liver fibrosis due to hepatitis C following liver transplant. Int J Biostat 2010;6:Article 7. [PMID: 20305705 DOI: 10.2202/1557-4679.1213] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 289 |
Kawada N, Imanaka K, Kawaguchi T, Tamai C, Ishihara R, Matsunaga T, Gotoh K, Yamada T, Tomita Y. Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis. J Gastroenterol 2009;44:1190-4. [PMID: 19672551 DOI: 10.1007/s00535-009-0112-0] [Cited by in Crossref: 155] [Cited by in F6Publishing: 168] [Article Influence: 11.9] [Reference Citation Analysis]
|
| 290 |
Adams L. Transient elastography in nonalcoholic fatty liver disease: making sense of echoes. Hepatology 2010;51:370-2. [PMID: 20054871 DOI: 10.1002/hep.23422] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 291 |
Castéra L, Sebastiani G, Le Bail B, de Lédinghen V, Couzigou P, Alberti A. Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C. J Hepatol 2010;52:191-8. [PMID: 20006397 DOI: 10.1016/j.jhep.2009.11.008] [Cited by in Crossref: 148] [Cited by in F6Publishing: 152] [Article Influence: 11.4] [Reference Citation Analysis]
|
| 292 |
Soden JS. Clinical assessment of the child with intestinal failure. Semin Pediatr Surg 2010;19:10-9. [PMID: 20123269 DOI: 10.1053/j.sempedsurg.2009.11.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 293 |
Talwalkar JA. Antifibrotic therapies--emerging biomarkers as treatment end points. Nat Rev Gastroenterol Hepatol 2010;7:59-61. [PMID: 20051972 DOI: 10.1038/nrgastro.2009.197] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 294 |
Ayonrinde OT, Olynyk JK. PAHA model: an alternative non-invasive predictor of liver cirrhosis in patients with chronic hepatitis B infection. J Gastroenterol Hepatol 2010;25:3-4. [PMID: 20136968 DOI: 10.1111/j.1440-1746.2009.06041.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 295 |
Resino S, Micheloud D, Miralles P, Bellã³n J, Vargas A, Catalã¡n P, Ãlvarez E, Cosãn J, Lorente R, Lã³pez J, Muã±oz-fernã¡ndez M, Berenguer J. Diagnosis of advanced fibrosis in HIV and hepatitis C virus-coinfected patients via a new noninvasive index: the HGM-3 index: Diagnosis of advanced fibrosis. HIV Medicine 2010;11:64-73. [DOI: 10.1111/j.1468-1293.2009.00745.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 296 |
Kowdley KV. Cirrhosis. Netter's Gastroenterology 2010. [DOI: 10.1016/b978-1-4377-0121-0.50237-3] [Reference Citation Analysis]
|
| 297 |
O’leary JG, Davis GL. Hepatitis C. Sleisenger and Fordtran's Gastrointestinal and Liver Disease 2010. [DOI: 10.1016/b978-1-4160-6189-2.00079-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 298 |
Wasmuth H, Trautwein C. Leberfibrose: Klinik, Diagnostik und Management. Internist 2010;51:14-20. [DOI: 10.1007/s00108-009-2409-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 299 |
Domínguez M, Colmenero J, Bataller R. Tratamiento de la fibrosis hepática. Gastroenterología y Hepatología 2009;32:627-32. [DOI: 10.1016/j.gastrohep.2009.02.015] [Reference Citation Analysis]
|
| 300 |
Poynard T, Muntenau M, Morra R, Ngo Y, Imbert-Bismut F, Thabut D, Messous D, Massard J, Lebray P, Moussalli J. Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update. Gastroenterol Clin Biol. 2008;32:8-21. [PMID: 18973843 DOI: 10.1016/s0399-8320(08)73990-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 301 |
Guéchot J, Lasnier E, Sturm N, Paris A, Zarski JP. Automation of the Hepascore and validation as a biochemical index of liver fibrosis in patients with chronic hepatitis C from the ANRS HC EP 23 Fibrostar cohort. Clin Chim Acta. 2010;411:86-91. [PMID: 19850017 DOI: 10.1016/j.cca.2009.10.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 302 |
Popov Y, Schuppan D. Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Hepatology 2009;50:1294-306. [PMID: 19711424 DOI: 10.1002/hep.23123] [Cited by in Crossref: 229] [Cited by in F6Publishing: 247] [Article Influence: 16.4] [Reference Citation Analysis]
|
| 303 |
Andersen ES, Christensen PB, Weis N. Transient elastography for liver fibrosis diagnosis. European Journal of Internal Medicine 2009;20:339-42. [DOI: 10.1016/j.ejim.2008.09.020] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 304 |
Lee AU. When liver stiffness is not so straight forward and Fibroscan not so simple. J Gastroenterol Hepatol 2009;24:934-6. [PMID: 19638074 DOI: 10.1111/j.1440-1746.2009.05840.x] [Reference Citation Analysis]
|
| 305 |
Carrión JA. Utilidad del Fibroscan® para evaluar la fibrosis hepática. Gastroenterología y Hepatología 2009;32:415-23. [DOI: 10.1016/j.gastrohep.2009.01.178] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 306 |
Friedrich-Rust M, Zeuzem S. Reproducibility and limitations of transient elastography. Liver Int 2009;29:619-20. [PMID: 19413664 DOI: 10.1111/j.1478-3231.2009.02032.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 307 |
Castera L. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis. J Viral Hepat 2009;16:300-14. [PMID: 19254351 DOI: 10.1111/j.1365-2893.2009.01087.x] [Cited by in Crossref: 119] [Cited by in F6Publishing: 108] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 308 |
Ogawa E, Furusyo N, Toyoda K, Takeoka H, Maeda S, Hayashi J. The longitudinal quantitative assessment by transient elastography of chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin. Antiviral Res. 2009;83:127-134. [PMID: 19443053 DOI: 10.1016/j.antiviral.2009.04.002] [Cited by in Crossref: 107] [Cited by in F6Publishing: 112] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 309 |
Zarski JP. [Clinical case: treatment of chronic hepatitis B]. Gastroenterol Clin Biol 2009;33:358-60. [PMID: 19345534 DOI: 10.1016/j.gcb.2009.02.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 310 |
Olynyk JK, Gan E, Tan T. Predicting iron overload in hyperferritinemia. Clin Gastroenterol Hepatol 2009;7:359-62. [PMID: 19095082 DOI: 10.1016/j.cgh.2008.11.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 311 |
Fang ZX, Li XB, Liu JJ, Geng Z, Tian Q. Therapeutic effects of Lanyuzan granules on hepatic fibrosis in rats. Shijie Huaren Xiaohua Zazhi 2009; 17(1): 11-16 [DOI: 10.11569/wcjd.v17.i1.11] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 312 |
Bedossa P, Carrat F. Liver biopsy: the best, not the gold standard. J Hepatol 2009;50:1-3. [PMID: 19017551 DOI: 10.1016/j.jhep.2008.10.014] [Cited by in Crossref: 228] [Cited by in F6Publishing: 236] [Article Influence: 16.3] [Reference Citation Analysis]
|
| 313 |
Bedossa P. Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsy. Liver Int 2009;29 Suppl 1:19-22. [PMID: 19207962 DOI: 10.1111/j.1478-3231.2008.01940.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 314 |
Kwon JH, Park ST, Kim GD, You CR, Kim JD, Woo HY, Jang JW, Kim CW, Bae SH, Choi JY, Yoon SK. The value of serum retinol-binding protein 4 levels for determining disease severity in patients with chronic liver disease. Korean J Hepatol 2009;15:59. [DOI: 10.3350/kjhep.2009.15.1.59] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 315 |
Alkhouri N, Zein NN. Hepatitis C in children and adolescents: The good, the bad, and the ugly. Curr hepatitis rep 2008;7:145-151. [DOI: 10.1007/s11901-008-0029-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 316 |
Loaeza-del-castillo A, Paz-pineda F, Oviedo-cárdenas E, Sánchez-ávila F, Vargas-vorácková F. AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis. Annals of Hepatology 2008;7:350-7. [DOI: 10.1016/s1665-2681(19)31836-8] [Cited by in Crossref: 134] [Cited by in F6Publishing: 138] [Article Influence: 8.9] [Reference Citation Analysis]
|
